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1.2. Abstract 
Background: Imaging is widely used to quantify glaucomatous structural 
changes. Although previous studies have examined the relationship between 
structure and function, measured using standard automated perimetry (SAP), the 
true relevance of structural changes remains poorly understood.  
Aim: The aim of this body of work was to explore the structure-function 
relationship and to ascertain the point at which structural changes become 
associated with impaired ability to perform vision-dependent tasks. 
Plan of research: After critically appraising previously described structure-
function models, an investigation was conducted progressively evaluating the 
relationship between glaucomatous structural changes and 1) estimated loss of 
retinal ganglion cells (RGCs), 2) an objective measure of visual function (the pupil 
response), and 3) a vision-related task relevant to quality of life (driving). 
Results: Localised RNFL defects visible on photographs, a common 
manifestation of glaucoma, were associated with large estimated RGC losses. 
However, problems were identified with the published method of RGC estimation. 
Asymmetric RNFL thinning was also found to be associated with asymmetry of 
the pupil response, and the magnitude of asymmetry required for a clinically 
detectable relative afferent pupillary defect (RAPD) was calculated. Finally, loss 
of RNFL was associated with worse ability to perform a simulated driving task, 
providing additional information to SAP alone.  
Significance: Glaucomatous structural defects may be associated with 
significant functional impairment. Incorporating information from both structure 
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and function may improve our ability to predict patients at risk of developing 
problems with vision-related tasks of daily living.   
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2.1. Glaucoma 
Glaucoma is a leading cause of blindness, affecting more than 70 million 
people worldwide, of whom approximately 10% are blind in both eyes (Quigley, & 
Broman 2006). Treatment is often effective at slowing progression but as 
glaucoma does not usually produce symptoms until the later stages, a large 
proportion of individuals affected remain undiagnosed. Population-based surveys 
suggest only 10% to 50% of people with glaucoma are aware they are affected 
and consequently there are many people losing vision without receiving 
appropriate treatment (Rotchford et al 2003; Hennis et al 2007; Budenz et al 
2013). 
Histologically, glaucoma is characterized by loss of RGCs with resultant 
structural changes to the ONH and inner retina. Dysfunction and loss of RGCs is 
accompanied by loss of visual field, which can be quantified using automated 
perimetry (Weinreb et al 2014).  Although the pathophysiology of glaucoma is not 
fully understood, elevated IOP, which is related to the balance between aqueous 
humour secretion by the ciliary body and outflow through the trabecular 
meshwork and uveoscleral outflow pathway, is the major risk factor. Raised IOP 
results in mechanical stress and strain to the ONH, which is believed to lead to 
disruption of axonal transport and interruption of retrograde supply of 
neurotrophic factors essential for RGC survival (Burgoyne et al 2005). 
Detection of glaucoma has relied historically on detection of raised IOP, 
however IOP is a poor discriminator of health and disease. Substantial numbers 
of people with elevated IOP do not need treatment and will never develop 
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glaucoma, while conversely many patients with glaucoma have IOP within the 
range of that expected for the population (Kass et al 2002; Weinreb et al 2014). 
The key to glaucoma diagnosis is recognition of the morphological changes to the 
ONH and RNFL that result from RGC loss. However, it is functional losses that 
are of greater clinical importance, as loss of visual function is ultimately what 
matters most to the patient. The relationship between these structural and 
functional changes has been an important, and somewhat controversial, area of 
study (Medeiros et al 2016). 
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2.2. Measuring Structural and Functional Changes 
2.2.1. Structural changes 
2.2.1.1. Detecting glaucoma 
Glaucomatous structural changes are typically detected using slit lamp 
fundoscopic examination or by observing for changes on stereophotographs, with 
typical features including narrowing of the neuroretinal rim, increased ONH 
excavation, increased CDR, and loss of the RNFL (Jonas et al 1999). However 
due to the wide variation in normal ONH appearance, diagnosis based on a 
single examination can be challenging. For example, the European Optic Disc 
Assessment Study showed that although ophthalmologists classify discs 
moderately well, with an average diagnostic accuracy of 80%, there is wide 
variation, with some ophthalmologists achieving an accuracy of only 60% (Reus 
et al 2010). Using the same set of disc photographs, similar findings were 
reported for UK optometrists, though optometrists had slightly higher sensitivity 
and lower specificity compared to ophthalmologists (Hadwin et al 2013). 
The last 25 years has seen the introduction of ocular imaging devices such 
OCT (Figure 2-1), CSLO and SLP which enable clinicians to obtain objective 
quantitative measurement of ocular structure (Huang 1991; Wollstein et al 2000; 
Wollstein et al 1998; Zangwill et al 2001; Greaney et al 2002; Chang et al 2009; 
Mwanza et al 2012; Leung et al 2010; Medeiros et al 2008; Medeiros et al 2004; 
Strouthidis et al 2006). Imaging devices provide high-resolution topographic 
images of the ONH and RNFL and using sophisticated software can quantify 
these structures. The devices also contain normative databases so that observed 
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measurements can be compared to the normal range and eyes classified as 
normal, borderline or outside normal limits (Realini et al 2014). 
Figure 2-1. Typical OCT summary showing RNFL thickness outside normal limits 
in the right eye and borderline in the left eye. 
 
Imaging devices seem to have comparable or better ability to detect 
glaucoma compared to assessment of optic disc photographs (Reus et al 2010).  
In the European Optic Disc Assessment Trial, CSLO and GDx-VCC had better 
diagnostic accuracy than clinicians grading disc photographs, correctly classifying 
93.2% and 89.8% of eyes respectively, compared to 80.5% for clinicians (Reus et 
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al 2010). However, of current imaging devices, OCT offers greatest versatility and 
it is OCT that has come to the fore in glaucoma imaging.  
OCT was first used to image the eye in 1991 but has since evolved 
considerably (Figure 2-2) (Huang 1991). The original technology of TDOCT has 
been superseded by SDOCT, which offers enhanced image quality due to 
improved spatial resolution and averaging of multiple images within each scan, 
made possible by a faster scan speed. SSOCT, which uses a longer wavelength 
light source of 1050nm to allow deeper tissue penetration, is another recent 
development.   
Figure 2-2. The first published OCT image of the human eye in 1991 (adapted from 
Huang, 1991) and a wide field SSOCT image from 2016 obtained using the Topcon 
DRI-OCT. 
 
OCT can be used to obtain measurement of cpRNFL thickness, ONH 
parameters such as BMO-MRW, and macular thickness, with multiple studies 
demonstrating the ability of these parameters to differentiate glaucomatous and 
healthy eyes. Studies examining the ability of TDOCT to distinguish 
glaucomatous and healthy eyes have reported specificities of approximately 90%, 
with sensitivities of 70 to 80% (Budenz et al 2005; Bengtsson et al 2012; Deleón-
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Ortega et al 2006).  Using the Cirrus SDOCT (Carl Zeiss Meditec Inc.), Leung 
and colleagues found cpRNFL measurements to have a sensitivity of 91.6%, for 
a specificity of 87.6%, and an AUC of 0.962 (Leung et al 2009). Therefore, 
SDOCT achieves only slightly better sensitivity and specificity than TDOCT but 
has the advantage of lower measurement variability, which may allow it to better 
detect glaucoma progression than the older technology (Leung et al 2009; Leung 
et al 2011; Park et al 2009). Other studies examining the ability of SDOCT 
measurements to detect glaucoma are summarised in Table 2-1. 
While these studies mainly report excellent AUCs, the results must be 
interpreted with some caution. Direct comparison of studies is somewhat 
problematic due to different reference standards employed and variable disease 
severities of included subjects.  Many studies included subjects with significant 
visual field loss, in whom the use of OCT may add little to the diagnostic process. 
For example, the average MD of glaucomatous subjects in the 2009 study by 
Leung et al was -10.36 dB (Leung et al 2009). In an eye with a MD of -10.36 dB it 
is highly likely that the diagnosis of glaucoma could be made without recourse to 
OCT. A more clinically relevant question may be whether imaging is of value as a 
supplementary test in cases of diagnostic uncertainty, such as those with suspect 
glaucoma, or in other words, those with suspicious optic nerve appearance on 
fundoscopy but normal (or unreliable) visual field. 
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Table 2-1. Summary of selected studies examining the diagnostic ability of 
spectral domain optical coherence tomography (SDOCT) in glaucoma. 
 
Study Number of Eyes SAP Mean 
deviation 
(dB) 
SDOCT device Parameter AUC 
Leung et al 
2009 
83 Glaucoma 
97 Healthy 
-10.36 
-0.79 
Cirrus cpRNFL  0.962 
Leung et al 
2010 
79 Glaucoma 
76 Healthy 
-10.36 
-0.79 
Spectralis cpRNFL  0.978 
Mwanza et al 
2011 
73 Glaucoma 
146 Healthy 
-10.4 Cirrus Rim area 
cpRNFL 
0.96 
0.95 
Mwanza et al 
2012 
58 Glaucoma 
99 Healthy 
-3.2 
0.08 
Cirrus Rim area 
cpRNFL  
mGCIPL  
 
0.91 
0.94 
0.94 
Sung et al 
2012 
144 Early Glaucoma 
109 Healthy 
-2.54 
-0.45 
Cirrus Rim area 
cpRNFL  
0.831 
0.943 
Takayama et 
al 2012 
38 Early Glaucoma 
48 Healthy 
-2.33 
-0.07 
Cirrus cpRNFL  
mGCIPL  
Minimum 
mGCIPL 
0.89 
0.82 
 
0.90 
Lisboa et al 
2012 
48 Preperimetric 
Glaucoma 
86 Healthy 
-0.63 
 
0.09 
Spectralis cpRNFL  0.86 
Wu et al 2012 Early Glaucoma 
85 Healthy 
> -6 
-1.25 
Spectralis cpRNFL  0.895 
Lisboa et al 
2013b 
48 Preperimetric 
Glaucoma 
94 Healthy 
-0.81 
 
0.02 
RTVue Rim area 
cpRNFL  
mGCC  
0.72 
0.89 
0.79 
Jeoung et al 
2014 
164 Early Glaucoma 
119 Healthy 
-2.68 
-0.22 
Cirrus Rim area 
cpRNFL  
mGCIPL  
Minimum 
mGCIPL 
0.86 
0.90 
0.82 
 
0.90 
Begum et al 
2014 
21 Preperimetric 
Glaucoma 
53 Healthy 
-1.9 
 
-2.0 
Cirrus Rim area 
cpRNFL 
mGCIPL  
 
0.85 
0.79 
0.59 
 
Abbreviations: SAP = standard automated perimetry, AUC = area under the receiver operating 
characteristic curve, cpRNFL = circumpapillary retinal nerve fibre layer, mGCIPL = macular 
ganglion cell layer and inner plexiform layer thickness, mGCC = macular ganglion cell complex 
thickness (mGCIPL + mRNFL). 
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Lisboa and colleagues recently examined the ability of SDOCT and CSLO 
to different eyes with suspected glaucoma from those with preperimetric changes 
(Lisboa et al 2012). Preperimetric glaucoma was defined by the presence of 
progressive glaucomatous changes on optic disc stereophotographs with normal 
SAP. 134 eyes of 88 subjects suspected of having glaucoma due to optic disc 
appearance were enrolled at baseline. Over 5 years of follow-up 48 eyes 
developed preperimetric glaucoma. SDOCT could discriminate eyes with 
preperimetric glaucoma from those with suspected glaucoma with an AUC of 
0.86 for global cpRNFL thickness. Subjects were also tested using CSLO, 
however the best performing CSLO parameter, global rim area, had an AUC of 
only 0.72, which was significantly less than the best performing SDOCT 
parameter of temporal superior cpRNFL thickness with an AUC of 0.88 (P = 
0.008). Leite and colleagues also demonstrated the effect of disease severity on 
diagnostic performance of Cirrus SDOCT (Leite et al 2010).  For a specificity of 
85%, average cpRNFL thickness had an estimated sensitivity of 82% in eyes with 
early disease (defined using the independent reference of SAP VFI of 90%), 
compared to a sensitivity of 93% in those with advanced disease (SAP VFI of 
70%).  
Measurement of cpRNFL though has some limitations. The circumpapillary 
scan includes non-neural tissue such as blood vessels located within the RNFL 
and the scan may also pass through areas of parapapillary atrophy. To more 
accurately detect structural abnormalities, it is important to choose measures that 
use anatomically accurate landmarks as their reference point. In addition to 
measuring cpRNFL thickness, SDOCT provides a means to acquire 3D images 
of the ONH from which parameters such as rim area, cup to disc ratio and cup 
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volume can be measured; however, these parameters may not perform as well 
as cpRNFL thickness, especially in early disease (Sung et al 2012; Lisboa et al 
2012; Lisboa et al 2013) For example, in a study including 144 eyes with early 
glaucoma and 109 healthy controls, Sung and colleagues found cpRNFL 
thickness to perform better than SDOCT ONH parameters (Sung et al 2012), 
which was similar to the findings of Lisboa and colleagues using CSLO and 
SDOCT (Lisboa et al 2012; Lisboa et al 2013).  
Measurements of the macula may also be useful for detecting glaucoma, 
with the macula an attractive region for imaging due to its importance for central 
vision and its relative consistent structure between healthy individuals.  Macula 
measurements may also be less affected by non-neural structures such as blood 
vessels than the cpRNFL and, therefore, less prone to OCT segmentation 
software failures.  Several recent studies have shown that macular thickness 
measurements, which include mGCIPL and mGCC thickness have good ability to 
detect glaucoma (Garas et al 2011; Tan et al 2009; Mwanza et al 2012).  
mGCIPL includes the ganglion cell layer and inner plexiform layer and mGCC 
includes these layers plus the macular RNFL. Mwanza and colleagues recently 
reported mGCIPL measurements to have similar ability to detect glaucoma 
compared to cpRNFL (Mwanza et al 2012), however, others have found mGCIPL 
may perform less well than cpRNFL in early disease. Lisboa and colleagues 
reported AUCs of 0.79 and 0.89 for mGCC and cpRNFL respectively for 
differentiating eyes with preperimetric glaucoma from those suspected of having 
the disease (Lisboa et al 2013).  
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Following clinical observations and histological and SDOCT studies in 
non-human primates, Chauhan and colleagues recently proposed a novel 
structural measure for glaucoma, known as the BMO-MRW (Chauhan et al 
2013).  Traditionally the outer border of the neuroretinal rim is defined by the 
optic disc margin, however, this is not a sound landmark as measurements from 
disc margin to inner rim are affected by tissue orientation and the neuroretinal rim 
may extend inside the disc margin. Furthermore, clinicians differ in their 
assessment of the location of the optic disc margin and SDOCT cannot be used 
to aid identification, as the disc margin does not correspond to an anatomical 
structure visible on SDOCT. The BMO-MRW is a measure of minimum rim width 
from the true outer border of the rim, which is Bruch’s membrane opening (BMO). 
The BMO is usually identifiable on SDOCT of the ONH and hence BMO-MRW 
measurements have a high level of reproducibility.  In a study of 107 patients with 
early glaucoma (average MD of -3.92 dB) and 48 healthy controls, Chauhan and 
colleagues reported BMO-MRW to have a sensitivity of 81% for detecting 
glaucoma at 95% specificity, compared to a sensitivity of only 70% for cpRNFL 
thickness for similar specificity (Chauhan et al 2013). BMO-MRW is a promising 
parameter for glaucoma detection and monitoring for structural progression 
however further studies are needed.  
As more parameters become available clinicians may decide to use 
multiple measures to detect disease or monitor for progression. This approach 
may lead to confusion when change occurs in one structural parameter but not 
another and increase the chance of falsely identify change when none has 
occurred. It should also be acknowledged that each of these parameters was 
evaluated in case-control series using strict inclusion criteria and so might not 
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reflect the ability of imaging devices to detect disease in real world practice. 
Recently Azuara-Blanco and colleagues, based in Belfast, examined the ability of 
SDOCT normative databases to distinguish glaucomatous and healthy eyes 
among patients referred from community optometrists to glaucoma clinics 
(Banister et al 2016). Using a reference standard for glaucoma as diagnosis of 
glaucoma by the ophthalmologist, without recourse to OCT, an OCT global 
classification of ‘outside normal limits’ achieved 77% sensitivity for 79% 
specificity. Therefore, OCT classification alone missed 20% of people who had 
glaucoma and resulted in a 20% false positive rate; a poor result, likely in part 
due to limitations of the normative database. OCT also missed 5% of cases of 
severe glaucoma indicating that imaging for structural changes should not be 
relied on alone to detect disease; visual fields remain essential.  
 
2.2.1.2. Detecting progression 
The assessment of structural changes is also important for attempting to 
detect change over time; with the gold standard masked grading of optic disc 
stereophotographs (Medeiros et al 2005).  Glaucoma guidelines, such as those 
published by the UK National Institute of Clinical Excellence, also recommend 
obtaining baseline optic disc images for progression analysis (2009). However, 
even expert observers often fail to agree on the presence or absence of 
progression on optic disc photographs, limiting the reliability of monitoring for 
structural changes using this method (Azuara-Blanco et al 2003; Jampel et al 
2009).  
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Imaging devices such as OCT can provide supplementary information and 
include progression analysis software to provide a quantitative measure of 
change by performing event and trend-based analyses. In event analysis, 
progression is deemed to occur when the difference between the baseline and 
subsequent measurements is greater than test-retest variability (Leung 2014). 
Trend analysis uses linear regression analysis over time to determine if there is a 
significant negative slope in measured parameters, representing a fast rate of 
change. The Guided Progression Algorithm (GPA) on Zeiss devices is one 
example of OCT progression software. The GPA performs both trend-analysis 
and an event-analysis that examines RNFL thicknesses at individual pixel 
locations and compares two baseline OCT images to a follow up scan. 
OCT is more objective than disc photographs and has good short-term 
reproducibility, making it an attractive option for detecting progression. Mwanza 
and colleagues examined 55 patients with glaucoma using the Cirrus OCT and 
performed 3 scans during the same visit to examine intravisit reproducibility and 
then 4 scans on additional days to measure intervisit reproducibility (Mwanza et 
al 2010). cpRNFL measurements had excellent reproducibility leading to the 
conclusion that a decrease in cpRNFL thickness at least 4μm is likely to 
represent significant change (Mwanza et al 2010). However, it is important to 
note that this study did not examine long-term reproducibility, which may be less 
than short-term reproducibility; meaning larger changes in cpRNFL thickness 
may be needed to be confident change is genuine. Also, as cpRNFL thickness 
decreases with age at a rate of approximately 0.5 μm per year (Leung et al 
2012), the change of 4μm suggested as significant by Mwanza and colleagues 
could occur in 8 years with normal ageing. 
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The first paper to evaluate OCT as a tool to detect glaucoma progression 
was published in 2005 (Wollstein et al 2005). Wollstein and colleagues used a 
prototype OCT device to measure cpRNFL thickness in 63 eyes with glaucoma or 
suspected glaucoma and followed them every 6 months over an average of 
almost 5 years. 22% of eyes progressed by OCT event analysis (defined as a 
reduction in cpRNFL thickness of at least 20 μm from baseline) compared to only 
9% by visual field and 3% by both. However, as the study did not include an 
independent reference for progression it is difficult to determine if progression 
noted by OCT was true deterioration or due to false-positives. 
Rates of change in eyes with glaucoma are highly variable (Leung 2014; 
Wollstein et al 2005; Medeiros et al 2009). In a study of 116 glaucomatous eyes 
of 64 patients followed for at least 3 years with Stratus TDOCT, Leung and 
colleagues reported a wide range of rates of change in cpRNFL thickness 
ranging from -1.2 to -15.4 μm per year (Leung et al 2010). However, such inter-
individual variability is to be expected, especially given the known variability in 
rates of change in visual field sensitivity in patients with glaucoma (Section 
2.2.2.2, page 41).  Medeiros and colleagues also used Stratus TDOCT to 
examine 253 eyes with glaucoma or suspected glaucoma over an average follow 
up of 4 years (Medeiros et al 2009). Rates of cpRNFL loss were significantly 
faster in eyes progressing on SAP and optic disc stereophotographs compared to 
those not progressing using conventional measures, with average rates of 
cpRNFL loss of 0.72 μm per year and 0.04 μm per year respectively.  
The finding that eyes progressing on SAP have faster rates of cpRNFL 
loss than non-progressing eyes provides some validity for the use of OCT 
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measurements of cpRNFL thickness as a surrogate for glaucoma progression. 
However, several studies have shown progression is rarely detected 
simultaneously in structural and functional domains, a subject discussed further 
in section 2.3, page 51). There are also limitations of using TDOCT that may 
decrease its ability to detect change. In particular, the measurements obtained 
using TDOCT are not registered and differences in scan alignment over time will 
considerably weaken performance (Leung 2014).  
SDOCT uses strategies such as eye tracking and scan registration to 
attempt to obtain images from the same location at each visit to more accurately 
detect change. In the first study to examine glaucoma progression using SDOCT, 
Leung and colleagues compared the performance of TDOCT and SDOCT for 
detecting structural changes in glaucomatous eyes (Leung et al 2011). The 
agreement for detecting progression (using trend-analysis) between devices was 
poor (K = 0.188), with SDOCT identifying more eyes as progressing compared to 
TDOCT (19/81 (23.5%) versus 4/81 (4.9%) respectively). Rates of changes in 
cpRNFL thickness ranged between −1.52 μm per year and −5.03 μm per year 
using Cirrus SDOCT and between −2.22 μm per year and −7.60 μm per year 
using Stratus TDOCT (Leung et al 2011). The authors concluded that the 
discrepancy might be due to SDOCT detecting progression earlier, however it is 
difficult to be certain whether some eyes thought be progressing on SDOCT were 
false-positives, especially as in keeping with other studies, both TDOCT and 
SDOCT had poor agreement with progression on SAP VFI. Nevertheless, it is 
intuitive that SDOCT is likely to be better at detecting progression than TDOCT 
due to its improved reproducibility. OCT measurements of macular thickness may 
also be useful for detecting glaucoma progression; with one study suggesting 
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they may be particularly useful for monitoring advanced glaucoma when cpRNFL 
measurements are nearing their floor (Sung et al 2012). 
Despite these improvements in imaging technology, there are several 
limitations of using OCT to measure progression. First, it is important to 
differentiate decreases in cpRNFL and macular thickness due to glaucoma from 
normal age-related changes (Leung et al 2013). Using the Cirrus OCT, Leung 
and colleagues reported an average age-related decrease in cpRNFL thickness 
of 0.52 μm per year (95% CI 0.17 to 0.86 μm per year) in 35 healthy subjects 
followed for an average of 30 months (Leung et al 2012), and others have found 
similar age-related changes (Celebi, & Mirza 2013). Leung and colleagues found 
50% of eyes with glaucoma had statistically significant downward slopes in inner 
macular thickness over an average follow up of almost 4 years (Leung et al 
2013). However, after accounting for age-related changes, this decreased to 20% 
of eyes. Age-related changes also should be considered when examining change 
in cpRNFL thickness, however cpRNFL measurements were less influenced by 
age than macular measurements.  
A second limitation of using OCT to measure progression is the floor in 
measurements that occurs in advanced disease at approximately 50 μm due to 
limitations of the segmentation algorithms and residual non-neural tissue (Leung 
et al 2009). Moreover, even as the structural floor is approached patients still may 
have significant residual visual field. It is also important to be aware that faster 
rates of change in RNFL thickness occur in eyes with thicker RNFL at baseline 
(Leung et al 2013) and as the signal-to-noise ratio of OCT tends to decrease over 
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time due to media opacities, weaker signal strength may lead to the appearance 
of thinner RNFL.   
Finally, although imaging devices such as OCT are now widely used to aid 
glaucoma detection and to measure progression, the clinical relevance of these 
changes depends on their relationship to visual function, and this relationship is 
incompletely understood. Current understanding of the relationship between 
structural and functional changes is critically appraised in section 2.3, page 51.  
 
2.2.2. Functional Changes - SAP 
It is easy to appreciate the relevance of functional changes to the patient 
and the assessment of visual function is an essential component of glaucoma 
diagnosis and detection of progression, with SAP the current gold standard for 
assessing the functional domain.  SAP is a form of static threshold perimetry 
during which differential light sensitivity is measured at 54 test locations. The 
customary protocol is The Swedish interactive thresholding algorithm (SITA) -
Standard 24-2 test, which evaluates visual field sensitivity in the central 24 
degrees (Figure 2-3).  
The SAP report includes a series of summary indices including; MD – a 
weighted average of the total deviation values, where zero equates to no 
deviation from normal and more negative values indicate more advanced loss; 
PSD – a summary index of localized visual field loss; and GHT – which 
categorizes eyes as within normal limits, borderline, or outside normal limits 
based on a comparison of pattern deviation scores in superior and inferior visual 
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field. The VFI is another global index, which assigns a number between 1% and 
100% to the field, with 100% being the normal age-adjusted value (Bengtsson, & 
Heijl 2008). The VFI assigns greater weight to central test locations and the 
percentage of field remaining is calculated based on pattern or total deviations 
depending on the depth of loss. 
Figure 2-3. Standard automated perimetry using the 24-2 SITA threshold strategy 
for the right eye of the same patient shown in Figure 2-1 showing a glaucoma 
hemifield test (GHT) within normal limits and a mean deviation (MD) of -1.02 dB. 
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2.2.2.1. Detecting glaucoma 
SAP has good ability to detect glaucoma and, in some patients, an 
abnormal SAP result may be the earliest manifest sign of the disease, however in 
others structural changes may be detectable first (Kass et al 2002). The 
relationship and timing of structural and functional changes is discussed more in 
section 2.3, page 51.  
Overall SAP seems to have similar sensitivity and specificity for detecting 
glaucoma compared to imaging devices. Sample and colleagues evaluated the 
ability of SAP to differentiate healthy and glaucomatous eyes and found AUCs of 
0.762 for SAP PSD and 0.731 for SAP MD (Sample et al 2006).  SAP PSD had 
sensitivities of 48% and 52% for specificities of 90% and 80% respectively, 
compared to SAP MD sensitivities of 55% and 65%. Therefore, if SAP MD were 
used alone to detect glaucoma we would expect only 65% of glaucomatous 
subjects to be correctly identified and a relatively large number of false positives 
(20%). These results are slightly worse than those reported by Banister and 
colleagues for OCT, which achieved 77% sensitivity for 79% specificity (Banister 
et al 2016), however Sample and colleagues only evaluated SAP global indices, 
which are likely to perform worse than point-wise comparisons. Also, direct 
comparison of studies is problematic due to the different reference standards 
used and difference in disease severities of included patients. 
There is also some debate regarding which SAP summary index might be 
best for detecting glaucoma. MD performed better than PSD in Sample and 
colleagues study (Sample et al 2006), however OHTS suggested PSD might be a 
better indicator of early glaucoma than MD (Gordon et al 2002). However, as 
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PSD is a summary index of localised visual field loss, PSD alone is unlikely to 
detect generalised reductions in visual field sensitivity that may be an early 
indicator of glaucoma in some patients (Henson et al 1999). For these reasons, 
when considering whether a patient has glaucoma or not, it is important to 
examine the whole visual field print out and not just the summary indices, and to 
interpret the visual field in the context of other findings from history and 
examination; a combination of information from structural and functional 
assessments is needed. 
In common with most diagnostic tests including OCT, SAP is however less 
likely to be able to detect disease early compared to advanced disease (section 
2.2.1.1, page 25). Simply put, it is more difficult to detect subtle differences 
between health and early disease compared to large differences between health 
and advanced disease. To illustrate this point, Medeiros and colleagues 
evaluated the effect of disease severity on glaucoma detection using SAP 
(Medeiros et al 2006). For 80% specificity, the SAP summary index PSD had a 
sensitivity of 85% in eyes with marked glaucomatous structural changes (70% 
loss of neuroretinal rim area), compared to a sensitivity of only 40% in eyes with 
early disease (10% loss of neuroretinal rim area).  
 
2.2.2.2. Detecting progression 
In addition to its role in glaucoma diagnosis, SAP is central to the detection 
and quantification of glaucoma progression. In fact, perimeters include 
sophisticated progression analysis software for this purpose, such as the 
Humphrey Perimeter’s Guided Progression Analysis (GPA). GPA uses event 
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analysis to determine if there has been any statistical worsening of the visual field 
(based on significance limits for Pattern Deviation) and trend analysis to quantify 
the rate of change and aid the clinician in determining the patient’s lifetime risk of 
visual loss. The GPA event analysis applies the progression criteria used in the 
Early Manifest Glaucoma Trial (EMGT) (Leske et al 1999). ‘Possible Progression’ 
is defined as 3 or more test points with statistically significant deterioration on two 
consecutive follow-up fields compared to two baseline examinations, and ‘Likely 
Progression’ is present when the same 3 or more deteriorated test points appear 
in at least 3 consecutive follow-up fields.  Therefore at least 4 visual fields are 
required for the GPA event analysis to indicate ‘Possible Progression’ and 5 for 
‘Likely Progression’. 
The GPA also uses a trend analysis to perform linear regression and 
examine the rate of change in VFI over time. The regression line derived from the 
VFI of previous tests can then be extrapolated to predict future visual field losses 
and lifetime risk of blindness. VFI is preferred to MD as it is less influenced by 
media opacities and has a weighting for central vision (Bengtsson, & Heijl 2008), 
however rates of progression measured using VFI may be non-linear and are 
likely to vary depending on disease severity (Pathak et al 2013; Rao et al 2011). 
In addition, relying on global indices such as VFI to detect progression may result 
in delayed recognition that a patient is worsening if changes are localised. As 
glaucoma often affects localised areas, a more sensitive approach, is to perform 
point-wise linear regression (PLR) analyses for each visual field test location and 
assess the significance and slope (Viswanathan et al 1997).  Permutation 
analysis of point-wise linear regression (PoPLR) is a modification of PLR, 
reported to provide a better estimate of statistical significance of visual field 
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change (O'Leary et al 2012). PoPLR involves comparing change detected by 
PLR with change (or lack of change) in randomly reordered visual field tests from 
the same series. However, though PoPLR can help determine the probability 
change has occurred, it does not alter the rates of change calculated by PLR.  
A further analytical tool for assessing rates of change in visual field, known 
as Analysis with Non-Stationary Weibull Error Regression and Spatial 
Enhancement (‘ANSWERS’) was recently described by Zhu and colleagues (Zhu 
et al 2014). ‘ANSWERS’ takes account of the two important factors not 
accounted for with other methods; the increasing variability that occurs as 
differential light sensitivity declines, and the correlation between spatially related 
regions (Garway-Heath et al 2000). Unlike PoPLR, ‘ANSWERS’ provides the rate 
of change for individual locations of the visual field, in addition to the probability of 
progression. Although ‘ANSWERS’ is a relatively new technique, there is 
evidence that it is a sensitive method of detecting visual field progression and 
that it may be better at predicting future visual field loss than other trend-based 
methods (Zhu et al 2015). 
Several studies have examined rates of change in visual field in treated 
and untreated patients with glaucoma. The CNTGS and EMGT examined rates of 
field progression in untreated glaucoma (Anderson et al 2001; Heijl et al 2009). 
The average rate of change in MD in untreated NTG was 0.4 dB/year, compared 
to 1.08 dB/year in high-tension glaucoma and 3.13 dB/year in pseudoexfoliative 
glaucoma.  Rates in treated patients are reassuringly less, but most treated 
patients still show some progression. Over a mean follow up time of 7.8 years, 
Heijl and colleagues found most patients with glaucoma progressed despite 
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treatment (Heijl et al 2013). The average rate of change was only -0.80 dB/year, 
however 5.6% of patients progressed very quickly with rates faster than -2.5 dB/ 
year. 
Chauhan and colleagues’ large Canadian cohort of 2,324 patients with 
glaucoma and suspected glaucoma had a much slower average rate of change of 
only 0.05 dB/year, perhaps due to fewer patients with PXF and having eyes with 
less severe disease at baseline (Chauhan et al 2014). However, 4.3% of patients 
progressed at a fast rate (<-1 to -2 dB/year) and 1.5% progressed at a 
catastrophic rate (<-2 dB/year). Saunders and colleagues examined rates of field 
loss in 3,790 UK patients with glaucoma and also found a small proportion of 
patients to be progressing quickly (Saunders et al 2014). 7.5% of eyes 
progressed at a rate faster than 1dB/year and only 3% of eyes progressed at 
rates faster than 1.5 dB/year. Interestingly, rates of visual field loss may be 
slowing down due to improvements in treatment, with Boodhna and colleagues 
recently showing slower rates of field loss in patients diagnosed after 2003, 
compared to those diagnosed in 1999 to 2003 (Boodhna et al 2015). However, 
the proportion of patients showing fast (worse than 1.5 dB/year) rates of 
progression did not change remaining at 6%. 
Although SAP remains essential to the assessment of visual function in 
glaucoma, it has several limitations. It is patient’s least preferred test (Glen et al 
2014), it leads to greater patient anxiety than imaging (Chew et al 2016), it is 
influenced by media opacities such as cataract, and due to variability, multiple 
tests may be needed to be confident that change is genuine (Chauhan et al 
2008). In fact, in areas of the field with advanced damage, test-retest variability 
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may span the entire dynamic range of the test (Malik et al 2012). There is also 
disagreement between experts examining visual field series as to whether there 
has been progression or not. Viswanathan and colleagues found a correlation 
kappa of only 0.32 for agreement between experts viewing series of reliable field 
tests (Viswanathan et al 2003).  
 
2.2.3. Functional Changes – Other tests 
Other psychophysical tests of visual function have been developed as 
possible alternatives to SAP, for example, frequency doubling technology (FDT), 
short-wavelength automated perimetry (SWAP) and flicker-defined form (FDF) 
perimetry (Johnson et al 1993; Landers et al 2003; Liu et al 2011; Sample et al 
2006). These tests were developed with the aim of targeting subpopulations of 
RGCs by evaluating specific aspects of visual function, such as motion 
perception, contrast sensitivity or colour vision (Sample, & Weinreb 1990), 
however none have been shown to be superior to SAP (Burr et al 2007).  
It has been hypothesised that in its early stages, glaucoma may 
predominately damage magnocellular RGCs projecting to the magnocellular 
layers of the lateral geniculate nucleus, i.e., the magnocellular (M) pathway 
(Johnson et al 1993; Shabana et al 2003). FDT perimetry was designed to 
selectively evaluate the M pathway by determining the contrast sensitivity for 
detecting a high temporal frequency counter-phase flicker stimulus, however 
there is now evidence that the response to motion perimetry is in fact generated 
by many RGC types and is cortically mediated (White et al 2002). In contrast, 
SWAP was designed to the parvocellular blue-yellow RGCs projecting to the 
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parvocellular layers of the lateral geniculate nucleus, i.e., the parvocellular (P) 
pathway, by using a narrow band blue-violet stimulus (440-nm wavelength) 
against a bright yellow background illumination. However, like FDT, the response 
to SWAP is likely to be mediated by a different pathway than originally thought. 
The blue-yellow cells are in fact small bistratified RGCs, which project their axons 
to the koniocellular layers of the lateral geniculate nucleus (Dacey, & Lee 1994; 
Sample et al 2006).   
Whatever its exact mechanism, several studies have reported FDT to have 
good ability to detect glaucoma (Johnson, & Samuels 1997; Horn et al 2002; 
Quigley 1998; Cello et al 2000; Medeiros et al 2004), with at least one 
longitudinal study suggesting that, at least in some patients, abnormalities on 
FDT may precede SAP changes by several years (Landers et al 2003). However, 
most studies comparing functional tests were poorly designed, meaning their 
conclusions should be interpreted with caution. For example, Landers et al 
recruited patients with normal SAP at baseline, biasing the results in favour of 
FDT and poor choice of reference standard is a common problem. The ideal 
reference standard for comparison of functional tests is a structural marker of 
glaucoma, for example, progressive changes on optic disc photographs.  
Several studies comparing the ability of SAP, SWAP and/or FDT to detect 
glaucoma have used a structural reference standard, however they have reached 
different conclusions (Medeiros et al 2006; Liu et al 2011; Sample et al 2006; 
Tafreshi et al 2009). Sample and colleagues found first generation FDT to have 
higher sensitivity than both SAP SITA and full threshold SWAP (Sample et al 
2006). SWAP PSD and FDT PSD had AUCs of 0.775 and 0.875 respectively, 
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compared to 0.762 for SAP PSD for differentiating healthy eyes from those with 
progressive glaucomatous structural changes on stereophotographs. SWAP PSD 
achieved sensitivities of 45% and 48% for specificities of 90% and 80% 
respectively compared to sensitivities of 68% and 71% for FDT PSD for the same 
specificities. FDT was subsequently updated to Matrix FDT, which uses grating 
targets smaller than the original FDT to enable a 24-2 test strategy identical to 
SAP. Racette and colleagues reported Matrix FDT to be better than SAP for 
discriminating glaucomatous and healthy eyes (Racette et al 2008), however 
others have found no difference (Spry et al 2005). SWAP has also been modified 
over the years and now utilizes the SITA strategy to shorten the test duration. 
Despite these modifications, however, SWAP SITA generally does not have 
better diagnostic ability than SAP (Bengtsson & Heijl 2006). 
Recently Liu and colleagues reported the results of a study in which they 
compared the ability of the latest versions of each test (Matrix FDT, SWAP SITA 
and SAP) to detect glaucoma, using cpRNFL thickness as the reference standard 
for glaucoma diagnosis (Liu et al 2011). There was no significant difference in 
performance between SAP and Matrix FDT but both were superior to SWAP 
SITA, with sensitivities of 82%, 84% and 57% for SAP, Matrix FDT and SWAP 
SITA MD respectively for 90% specificity.  In a well-designed study, Tafreshi and 
colleagues also compared ability of SAP, Matrix FDT and SWAP SITA to 
distinguish glaucomatous and healthy eyes, but in contrast to Liu and colleagues 
found all 3 tests to be equally sensitive (Tafreshi et al 2009). The different results 
of these studies were probably due to differences in reference standard and 
subject selection. Liu and colleagues proposed that Matrix FDT might only 
outperform SAP in patients with early visual field loss; in which case inclusion of 
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patients with more advanced glaucoma is likely to diminish the ability to identify 
the optimum tests for detection of early disease (Liu et al 2011).  
In a study including 196 healthy eyes and 174 eyes with glaucoma, 
Medeiros and colleagues used a regression model to examine the effect of 
disease severity on the diagnostic performance of Matrix FDT and SAP 
(Medeiros et al 2006). Glaucoma severity was determined from CSLO 
measurements of neuroretinal rim. For Matrix FDT PSD, areas under the ROC 
curves for 10%, 30%, 50%, and 70% loss of neuroretinal rim area were 0.766, 
0.857, 0.922, and 0.962 respectively, compared to 0.638, 0.756, 0.852, and 
0.920 respectively for SAP. Therefore, although Matrix FDT and SAP had similar 
ability to detect glaucoma in eyes with advanced structural losses, in the 
regression model, Matrix FDT was predicted to have significantly larger AUC than 
SAP for eyes with only 10% and 30% loss of neuroretinal rim, suggesting Matrix 
FDT may perform better than SAP in early disease. For a 10% loss of rim area, 
the AUC for SAP SITA was 0.638, with a sensitivity of only 21% for 95% 
specificity. Matrix FDT had an AUC of 0.766 for 10% loss of rim area, with a 
sensitivity of approximately 31% for 95% specificity, increasing to 58% for 80% 
specificity. Therefore, even though Matrix FDT performed better than SAP in 
early disease, it is still possible that many cases of early glaucoma could be 
missed if Matrix FDT were used alone to detect disease. 
The FDF stimulus has recently been proposed as an alternative method 
for detecting glaucomatous visual loss (Lamparter et al 2012; Horn et al 2014). 
HEP uses the FDF stimulus, which is believed to stimulate the M-pathway (Mulak 
et al 2012). The stimulus consists of rapidly reversing black and white dots that 
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modulate in counter-phase at a temporal frequency of 15 Hz until the subject 
perceives an illusionary contour (edge) at the border of the random dot areas. 
The phase reversal frequency is varied to determine the minimum contrast 
needed for detection of the edge, which appears to the subject as a grey patch 
against the mean luminance background. Recent studies have examined the 
ability of FDF perimetry to detect glaucoma and compared it to Matrix FDT and 
SAP (Lamparter et al 2012; Horn et al 2014). Horn and colleagues tested 97 
subjects with early glaucoma defined by optic disc appearance and found SAP 
MD to be abnormal in 42 (Horn et al 2014). Of the 55 subjects with normal SAP, 
28 had abnormal FDF MD. 38 subjects had abnormalities on both SAP and FDF 
and 4 had abnormal SAP but normal FDF. This suggests that FDF may be able 
to detect glaucomatous functional changes at an earlier stage than SAP, though 
there is insufficient evidence at present to recommend this test. 
Despite the interest in novel methods of perimetry, SAP remains the gold 
standard and so was selected as the primary test of visual function for my 
studies. Although FDT, SWAP and FDF perimetry attempt to minimize potential 
input from other pathways, it is unlikely any stimulus can be 100% specific for a 
single subset of RGCs. Moreover, glaucoma may affect different types of RGC, 
therefore were a test to target a specific pathway, it may miss some patients with 
early glaucoma with loss of other RGC subtypes and may also be less able to 
detect progression through all stages of disease. (Yücel et al 2003; Sample et al 
2006). It is also important to be cautious when considering the introduction of a 
new clinical test as it may impact on the resources available to perform 
conventional SAP. Due to the variability inherent in psychophysical testing, when 
trying to detect glaucoma progression it is likely better to employ one method of 
  50 
testing frequently than employ several different testing strategies infrequently. 
Figure 2-4 shows an example of SDOCT, SAP, FDT and FDF perimetry.  
Figure 2-4. Optical coherence tomography (OCT), standard automated perimetry 
(SAP), Frequency doubling technology (FDT) perimetry and Heidelberg Edge 
Perimetry (HEP) for the right eye of a patient with glaucoma. Inferior retinal nerve 
fibre layer (RNFL) thinning (arrows) is visible on OCT maps as ‘cooler’ colours in 
the RNFL thickness map and red and yellow, indicating deviation from normal 
values, on the RNFL deviation map. SAP shows a small corresponding 
superonasal visual field defect which is more pronounced on FDT and HEP. 
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2.3.  The relationship between structural and 
functional changes 
The true relevance of structural changes in glaucoma depends on their 
relationship to visual function. Many previous studies have attempted to examine 
the relationship between structural and functional changes, however the 
relationship is complex (Malik et al 2012). In some eyes, structural changes are 
detected before functional changes, whilst in others functional changes are 
detected before structural changes, and in some structural and functional 
changes are detected concurrently (Kass et al 2002). Disagreement between 
tests can be confusing for the clinician; for example, when an eye shows 
progression in one domain but not the other it may be difficult to determine 
whether change is clinically significant.  This has led to debate about which 
method is better to detect progression – structure or function – and whether or 
when clinicians should choose one method versus the other as they monitor 
patients with glaucoma or those suspected of having the disease (Medeiros et al 
2016). 
Histological studies are often quoted as proof that large numbers of RGCs 
may be lost before visual field abnormalities are noted (Quigley et al 1989; 
Harwerth et al 2004; Kerrigan-Baumrind et al 2000). For example, in a study of 
cadaver eyes, Kerrigan-Baumrind and colleagues concluded that at least 23 to 
35% of RGCs would need to be lost for an abnormality on conventional 
perimetry, suggesting that in early disease, SAP may underestimate 
glaucomatous damage (Kerrigan-Baumrind et al 2000). However, the results 
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somewhat contradict this conclusion, indicating an eye with 100% of RGCs 
remaining would have an average loss of sensitivity of 5 dB. The study was also 
limited by inclusion of small numbers of eyes and at individual locations, the 
relationship between SAP sensitivity and RGC counts was highly variable. 
Moreover, as clinical studies have shown that the first manifest sign of glaucoma 
may be either a structural or functional loss it is essential to test both structural 
and functional domains (Kass et al 2002). In OHTS only 12 of 125 eyes (9.6%) 
that developed glaucoma during follow up had a visual field and structural 
endpoint detected concurrently, meaning there was often disagreement between 
tests (Kass et al 2002). 69 eyes (55.2%) had an optic disc endpoint first and 44 
(35.2%) a visual field endpoint. Simultaneous detection of change in structure 
and function tests therefore seems to occur infrequently. 
The differences in structural and functional measures can be partially 
explained by differences in measurement scale (Garway-Heath et al 2000).  SAP 
is obtained and measured using a logarithmic decibel scale whilst structure is 
measured in linear units.  The consequence is that in the early stages of disease 
SAP data is compressed, meaning a large reduction in the structural parameter is 
likely to be accompanied by only a small change in SAP sensitivity. Conversely, 
later in the disease a small reduction in the structural parameter is likely to be 
accompanied by a large reduction in SAP sensitivity measured using logarithmic 
units (Garway-Heath et al 2000; Medeiros et al 2012; Hood, & Kardon 2007; 
Swanson et al 2004). Figure 2-5 shows the non-linear relationship between SAP 
MD in decibels and cpRNFL thickness using cross-sectional data taken from 
eyes included in DIGS at UCSD.  
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Figure 2-5. Scatter and LOWESS plot showing cpRNFL thickness (in the linear unit 
of μm) compared to SAP MD (in the logarithmic unit of decibels) for eyes included 
in DIGS.  
 
 
Figure 2-6 shows an example of how a large change in cpRNFL thickness in 
early glaucoma may be accompanied by only a small change in SAP sensitivity, 
whereas  
Figure 2-7 shows an example of how in advanced disease, SAP sensitivity may 
continue to decline with no detectable change in cpRNFL thickness.   
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Figure 2-6. Example of patient with early glaucoma showing progressive 
glaucomatous changes to the optic nerve but no significant change in SAP. The 
right eye has increased excavation of the optic nerve head visible on optic disc 
photographs between 2004 and 2008. During this period, OCT measurements of 
average cpRNFL thickness decreased at a rate of 3.2 μm per year, however 
there was no significant change in SAP sensitivity.  
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Figure 2-7. Example of a patient with advanced glaucoma showing progressive 
changes on visual field but no significant change in structural measurements. 
This patient has RNFL thickness approaching the floor in structural measures. 
 
 
When SAP sensitivities are transformed to a linear scale, the relationship 
between structure and function becomes more linear, with a linear relationship 
also observed between structural measures and other tests of visual function, 
including multifocal visual evoked potential (mfVEP) (Hood et al 2002) and 
pattern electroretinogram (PERG) (Garway-Heath et al 2002).  For example, 
Garway-Heath and colleagues showed a linear relationship between DLS (plotted 
on a 1/Lambert scale) and neuroretinal rim measured using CSLO (Garway-
Heath et al 2002). However simple transformation of data does not overcome 
other reasons for disagreement between SAP and structural measures. As DLS 
is assessed using a logarithmic stepped algorithm, there are few steps at high 
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sensitivity and many steps at low sensitivity. This leads to loss of information and 
lower precision at high sensitivity that is not compensated for by transforming 
SAP sensitivity values to linear units. It has been suggested that a linear testing 
strategy might be useful in early disease, however this would be problematic in 
advanced disease as the logarithmic scale provides a large amount of 
information at low sensitivities (Malik et al 2006). It may be that different 
algorithms could be adopted at different stages, such as a linear increment at 
high sensitivity and a logarithmic increment at low sensitivities, or an algorithm 
used where the step size is a percentage of the previous luminance value (Malik 
et al 2006). Several investigators have attempted to model the relationship 
between structural and functional measures and these are discussed further in 
section 2.4, page 62.  
Other reasons for disagreement between SAP and structural measures 
include sampling of different retinal areas, measurement variability inherent to 
SAP and OCT, overlap of RGC receptive fields, the contribution of non-neural 
components to RNFL thickness, and the effect of spatial summation (discussed 
further in section 2.4.10, page 76) (Malik et al 2012; Redmond et al 2013; 
Medeiros et al 2006; Garway-Heath et al 2000; Swanson et al 2004). The choice 
of statistical method also influences the apparent association between structure 
and function (Marín-Franch et al 2013). The relationship between structural and 
functional changes also differs at various stages of disease, with imaging devices 
appearing to be most useful in early disease, whereas perimetry seems to 
perform better when visual field losses are already present (Medeiros et al 2012). 
However, perhaps the most important reason for discrepancy between structure 
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and function is that RGCs may become dysfunctional before being lost 
completely.  
One should expect disagreement between structural and functional 
measurements due to different properties of the tests used to assess these 
changes, such as their different scales, variability and dynamic range. It is also 
important not to dismiss structural measures purely due to an imperfect 
agreement with functional tests.  Assessment of glaucomatous structural 
changes provides supplementary information to SAP and for some individuals 
offers an opportunity to detect disease and disease progression at an earlier 
stage. In addition, there is growing evidence that progressive structural changes 
are predictive of outcomes that are clinically relevant for patients.  
Several studies have examined whether baseline structural measurements, 
including from disc photographs, CSLO and OCT are predictive of future 
development of the clinically relevant outcome of visual field loss (Medeiros et al 
2009; Strouthidis et al 2010; Zangwill et al 2005; Lalezary et al 2006), however, 
overall there seems to be only weak association.  An analysis of 639 eyes of 407 
patients with suspected glaucoma from the DIGS at UCSD found baseline 
grading of disc photographs to be predictive of the development of abnormal 
visual fields over an average follow up of 8 years (Medeiros et al 2009). Eyes 
with an optic disc graded as glaucomatous at baseline had an almost 4 times 
increased risk of developing a visual field defect during follow up, with a 1.5-fold 
increase in risk for each 0.1 larger vertical cup disc ratio.  The presence of 
progressive changes on optic disc photographs was a much better indicator of 
risk, associated with almost 26 times higher chance of developing a field defect 
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(Medeiros et al 2009). Therefore, although baseline disc photographs were 
predictive of future functional change, progressive changes on disc photographs 
performed much better. 
Similar findings have been reported using CSLO and OCT. Strouthidis and 
colleagues found neither baseline MRA nor GPA classification alone were good 
at predicting future progression of visual field in patients with OHT (Strouthidis et 
al 2010), though abnormal CSLO at baseline was associated with increased risk 
of further structural changes. Although it is possible that baseline structural 
measures might have been better at predicting an alternative functional endpoint, 
they were also poorly predictive of future visual field loss in the CSLO ancillary 
study to the OHTS (Zangwill et al 2005). It seems likely that the poor 
performance of baseline structural measures is at least in part due to the wide 
variation in normal ONH appearance in healthy subjects, which frequently leads 
to difficulties in diagnosing glaucoma from a single disc examination, and 
therefore predicting risk of visual loss. Evidence of progressive structural damage 
seems to be a more robust indicator of glaucoma and more strongly predictive of 
progressive visual loss (Medeiros et al 2009). 
In those suspected of having glaucoma, longitudinal changes in rim area 
measured using CSLO are strong predictors of future visual field loss (Medeiros 
et al 2013). Over an average follow up of 7 years, Medeiros and colleagues found 
that patients who developed visual field loss had a mean rate of change in rim 
area almost four times faster than those that did not. Each 0.01mm2 / year faster 
rate of rim area loss was associated with an almost 3-fold higher risk of 
developing visual field loss. Progressive changes on CSLO are also predictive of 
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worsening visual field loss in patients with established glaucoma. Chauhan and 
colleagues examined 81 patients with glaucoma and found that progressive 
changes on CSLO topographic changes analysis during the first 3 years of follow 
up had earlier visual field progression defined using the EMGT criteria and worse 
rates of change in SAP MD (Chauhan et al 2009). It should be noted however 
that Chauhan’s study included only patients with a baseline MD between -2 and -
10 dB and the relationship between structural and functional changes is likely to 
be different at later stages of disease. A recent similar study examined rates of 
change in cpRNFL over time in patients with suspected glaucoma (Miki et al 
2014). Rates of cpRNFL thinning were significantly faster in eyes that eventually 
developed a visual field defect compared to those that did not, with each 1 μm 
per year faster cpRNFL loss associated with a greater than 2 times higher risk of 
developing a future field defect.   
Together these studies demonstrate that longitudinal glaucomatous 
structural changes are predictive of future visual loss, offering the opportunity to 
identify high-risk individuals and instigate treatment prior to worsening of 
functional impairment. It should be noted, however, that although abnormalities of 
RNFL thickness are often detected before changes on SAP, some patients 
develop visual field defects prior to the detection of structural changes. 
Assessments of both structure and function are needed; the difficulty lies in how 
best to integrate their results without increasing the chance of false-positives 
(discussed more in section 2.4.11, page 79). Also, whether progression is 
detected in the structural or functional domain first depends to a large degree on 
the choice of imaging and perimetric technology and the chosen endpoints.  For 
example, in OHTS, more eyes might have reached a structural endpoint first if 
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OCT measurements, rather than disc photographs, had been the chosen method 
of detecting structural change (Kass et al 2002; Medeiros et al 2016). Conversely 
functional changes might be detected earlier with improved methods of perimetry.  
Two recent studies from Claude Burgoyne and Brad Fortune in Portland, 
Oregon illustrate how choice of technology could influence the timing of disease 
detection.  Using an experimental model of glaucoma, it was found that, although 
there was a strong linear relationship between cpRNFL thickness and histological 
optic nerve axon count, cpRNFL thickness did not begin to decrease until 10 to 
15% of RGC axons were lost from the optic nerve (Cull et al 2012). This 
suggested that other structural changes might be detectable before RNFL 
thinning. As follow up to this work, Fortune and colleagues showed that loss of 
RNFL retardance measured using SLP could be detected in some eyes prior to 
cpRNFL thinning (Fortune et al 2013a). 41 rhesus macaques with experimental 
glaucoma had longitudinal SDOCT and SLP measurements. During follow up, 33 
of 41 eyes reached a structural endpoint and of these 79% had evidence of 
reduced RNFL retardance before a reduction in RNFL thickness. This 
observation suggests that axonal cytoskeletal disruption may precede axonal 
loss, and therefore measures of RNFL birefringence might allow earlier detection 
of glaucomatous damage than measures of RNFL thickness.  Whether an ability 
to detect structural changes prior to changes to cpRNFL will benefit patients is 
debatable however, as certainly the greatest unmet need is reducing the 
incidence of patients presenting with advanced disease. Also, the results of these 
animal studies may not be replicated in humans. A recent clinical study found 
progressive RNFL thinning occurred more frequently than changes in RNFL 
retardance (Xu et al 2013). It is also possible that other structural manifestations 
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of glaucoma such as changes in the ONH may be detected before RNFL loss (He 
et al 2014; Fortune et al 2013b). Nevertheless, this work provides insight into 
glaucoma pathogenesis and it’s conceivable that in the future, detection of other 
structural changes such as loss of retardance might allow treatment to be 
instigated before RGC axons are lost irreversibly. However, although RNFL 
retardance was measured using SLP devices, SLP has largely been abandoned 
in clinical practice in favour of OCT. It is also important to emphasise that there is 
also strong evidence that in some patients, functional changes precede changes 
to the RNFL. For example, Banitt and colleagues reported that a reduction of 
amplitude on pattern electroretinography (PERG) occurred several years prior to 
changes on OCT in a cohort of patients with suspected glaucoma (Banitt et al 
2013). 
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2.4. Comparing structure and function 
Various approaches have been described to facilitate the comparison of 
measurements of structure and function including; the Harwerth model (Harwerth 
et al 2010), Garway-Heath model (Garway-Heath et al 2000), Hockey-Stick 
model (Swanson et al 2004), Hood-Kardon model (Hood, & Kardon 2007), 
Drasdo model (Drasdo et al 2008) and Zhu model (Zhu et al 2010). To allow 
comparison between domains, measurements from SAP can be converted to 
linear units, structural measures converted to logarithmic units, or both structural 
and functional measurements converted to a common unit, for example an 
estimate of RGC number. The next section of this thesis appraises each of the 
structure-function models (section 2.4.4, page 66), but before considering the 
models it is important to appreciate that the ideal model should account for 3 
important factors; i) spatial summation, ii) stimulus modulation scale and iii) the 
contribution of non-neural components to structural measures (Malik et al 2012). 
 
2.4.1. Spatial Summation 
The relationship between glaucomatous structural changes, namely RGC 
loss, and functional changes, is influenced by visual processing mechanisms. 
Ricco’s law states that if a sufficiently small stimulus is projected onto the retina, 
the total energy of the stimulus required for threshold detection remains constant 
(Redmond et al 2010).  Therefore, for a small stimulus, the intensity of the 
threshold stimulus is inversely proportional to the stimulus area. The largest 
stimulus size for which Ricco’s law applies is known as Ricco’s area, or the 
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critical area. Stimuli smaller than or equal to the critical area meet the conditions 
for complete spatial summation, whereas when a stimulus is larger than the 
critical area, spatial summation is incomplete and the threshold is determined by 
probability summation. Detection of a stimulus by complete spatial summation 
depends on the summed response of detectors, whereas detection by probability 
summation depends on the non-linear pooling of responses (Mailk 2012}. 
Therefore, under conditions of complete summation, DLS is linearly related to the 
number of RGC receptive fields in the tested area (Garway-Heath et al 2000). 
Whereas under conditions of probability summation, the stimulus will be detected 
when recognized by at least one potential detector and the relationship between 
DLS and RGC count is determined by the relationship p=1-(1-p1)n, where p is 
the probability of detection, p1 is the probability of detection for each individual 
detector and n is the number of detectors (Pirenne 1943). The result of this 
exponential relationship is that with probability summation, reduction in DLS will 
be greater in regions of low RGC density than if the same number of RGCs were 
lost in a region of high RGC density.  
Due to the varying distribution of photoreceptors and RGCs, the critical area is 
larger in the peripheral compared to central retina, ranging from approximately -2 
log deg2 to 0.75 log deg2 in healthy individuals (Redmond et al 2010). The 
Goldmann III stimulus has an area of -0.83 log deg2, therefore in healthy eyes, 
SAP thresholds are determined by complete spatial summation only in the mid to 
peripheral visual field, corresponding to an eccentricity of approximately greater 
than 15 degrees (Redmond et al 2010).  
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The physiological basis of Ricco’s area is incompletely understood but it has 
been proposed that it increases with eccentricity to maintain a constant number 
of functioning underlying RGCs and that the critical number of RGCs is equal to 
the minimum number of RGCs needed to preserve detectability of a retinal signal 
against background cortical noise caused by spontaneous neural activity 
(Redmond et al 2010). Ricco’s area does not seem to change with age but 
enlarges when there is a pathological reduction in RGCs, such as occurs with 
glaucoma (Redmond et al 2010). As RGCs are lost, the area of complete spatial 
summation enlarges, and may encroach on the central 15 degrees, an area 
normally characterized by probability summation. Therefore, the relationship 
between DLS and RGC counts will vary depending on disease severity, and once 
complete spatial summation occurs, one would expect a given loss of RGCs to 
result in a greater decline in DLS. 
Improved understanding of spatial summation has the potential to lead to 
improved understanding of the structure-function relationship. It may also lead to 
improvements in perimetry, for example, if the perimetric stimulus size were 
scaled to account for changes in size of the critical area, the sensitivity of 
perimetry to detect small degrees of RGC loss could be improved, particularly in 
early disease and at locations close to fixation (Malik et al 2012).  However, 
background luminance, stimulus duration, and wavelength also influence spatial 
summation (Swanson et al 2004).   
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2.4.2. Stimulus modulation scale 
The relationship between measures of glaucomatous structural and functional 
change is influenced by the choice of scale used to acquire and present the data 
from each domain (Garway-Heath et al 2000). Therefore, models comparing 
structure and function must seek to overcome the difference between the 
logarithmic decibel scale used for SAP and linear structural measurements. 
Broadly, one of three approaches are used; either converting SAP data to 
1/Lambert units, converting structural data to logarithmic units, or converting both 
to a third unit, for example, an estimate of RGC count. It should be noted 
however, that these approaches do not overcome logarithmic algorithm used to 
acquire DLS values with SAP, previously discussed in more detail in section 2.3, 
page 51, of this thesis.  
 
2.4.3. Contribution of non-neural components  
Models comparing SAP and structural measurements should also consider 
the non-neural components of the RNFL and ONH. For example, in addition to 
RGC axons, the RNFL consists of astrocytes and Muller cells, and the relative 
contribution of each component changes over time in healthy and glaucomatous 
subjects due to tissue remodelling (Harwerth et al 2010). Harwerth and 
colleagues reported that loss of RGCs is likely to be proportionally greater than 
loss of RNFL due to non-neural components of the RNFL (Harwerth et al 2010). 
However, previous studies, albeit in low numbers of patients, have suggested an 
age-related rate of RGC loss of approximately 0.6% per year (Kerrigan-Baumrind 
et al 2000; Harman et al 2000) compared to age-related cpRNFL losses of 
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between 0.17 μm to 0.86 μm per year (Leung et al 2013), which assuming a 
baseline RNFL thickness of 100 μm would approximate to RNFL loss of 0.17 to 
0.86% per year (section 2.3, page 51).  
Whatever the exact rate of loss, the relative proportion of non-neural 
components is likely to increase with worsening RNFL loss, with non-neural 
components contributing most the RNFL as the floor in structural measures is 
reached at near 50 μm (Leung et al 2009; Harwerth et al 2010). This will have a 
direct effect on the relationship between structural and functional changes.  
 
2.4.4. Harwerth model 
The pathology underlying both structural and functional glaucomatous 
changes is dysfunction and loss of RGCs; therefore, both structural and 
functional changes should correlate to the number of RGCs and were it possible 
to quantify RGCs, this would be an attractive method of gauging glaucoma 
severity and comparing structural and functional domains. The Harwerth model 
attempts to estimate the number of RGCs based on formulae derived from 
studies in nonhuman primates with experimental glaucoma (Harwerth et al 2010; 
Harwerth et al 2004; Harwerth et al 2007). These experiments showed that, 
accounting for retinal eccentricity, there was a linear relationship between 
histological RGC density, transformed to a logarithmic scale, and SAP sensitivity 
in decibels (Harwerth et al 2004). The structure-function relationship was steeper 
at locations in the peripheral retina meaning loss of a given number of RGCs 
would result in a greater reduction in SAP sensitivity in the peripheral compared 
to the central retina (Figure 2-8). 
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Figure 2-8. The structure-function relationship between SAP sensitivity and 
histological RGC density in monkeys with experimental glaucoma at 4 retinal 
eccentricities. Both SAP sensitivity and RGC density are shown in logarithmic 
units Adapted from Harwerth et al (Harwerth et al 2010). 
 
 
The following formulae were then proposed to estimate the number of 
RGC somas in an area of the retina corresponding to a SAP test location for 
given values of SAP sensitivity (Harwerth et al 2004). The eccentricity of the test 
point is denoted ec, s is SAP sensitivity in decibels, and m and b represent the 
slope and intercept of the linear function relating RGC quantity (gc) in dB to SAP 
sensitivity (s) in dB at a given eccentricity. 
m = [0.054*(ec*1.32)] + 0.9 
b = [-1.5*(ec*1.32)] -14.8 
gc = {[(s-1)-b]/m} + 4.7 
SAPrgc = S 10^(gc*0.1) 
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The constant 1.32 is the ratio of human-monkey axial lengths to relate 
visual angles to retinal distance, -1 is a correction for the difference between full-
threshold and SITA standard tests, and 4.7 converts RGC density to total RGCs 
in an area of the retina corresponding to a 6 x 6 degree area of visual space.  By 
applying this formula to each SAP test location, an estimate of total number of 
RGCs (SAPrgc) may be obtained by summing the RGC estimates from all 
locations.  
The structural component of the model was derived from subsequent 
experiments in 2007 showing a linear relationship between histological RGC 
counts and cpRNFL thickness measured using TDOCT (Harwerth et al 2007). To 
derive the total number of RGC axons from the global RNFL thickness 
measurement obtained by OCT (OCTrgc), the following formulae were applied: 
d = (-0.007*age) + 1.4 
c = (-0.26*MD) + 0.12 
a = average RNFL thickness * 10870*d 
OCTrgc = 10^[(log(a)*10 -c)*0.1] 
where d corresponds to the axonal density (axons/µm2) and c is a correction 
factor for the severity of disease to consider remodelling of the RNFL. The model 
considers the effect of ageing on axonal density and the effect of disease severity 
on the relationship between the neuronal and non-neuronal components of the 
RNFL thickness estimates obtained by OCT. It is important to note however that 
SAP MD is used as the measure of disease severity and therefore the OCT-
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derived RGC estimate is not truly independent to the RGC estimate derived from 
SAP.  
When these formulae were applied to a clinical population there was good 
agreement between SAP and OCT-derived RGC estimates, although agreement 
was poorer in more advanced disease as apparent in Figure 2-9 (Harwerth et al 
2010). 
Figure 2-9. Scatter plot showing the relationship between estimated numbers of 
RGC axons derived from OCT and estimated number of RGC soma derived from 
SAP for 488 patients with glaucoma. Adapted from Harwerth et al 2010 (Harwerth 
et al 2010). 
  
The ability to express the results of structure and function tests using unit 
of estimated number of RGCs is intuitive as it reflects glaucoma pathology and 
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raises the possibility of combining information from the two domains to increase 
the precision of the RGC estimates (section 2.4.11, page 79).  
 
2.4.5. Garway-Heath model 
Garway-Heath and colleagues examined the physiological relationship 
between RGC receptive field numbers and differential light sensitivity (DLS) 
measured using SAP (Garway-Heath et al 2000).  RGC density values were 
derived from a previously published RGC density map of the healthy human 
retina, with a correction for lateral displacement of RGCs from the fovea, and 
these RGC densities were compared to corresponding normal DLS values from 
30-2 white-on-white perimetry (Curcio, & Allen 1990; Heijl et al 1987) . The 
number of RGC receptive fields within a Goldman size III target was calculated 
based on the size of the target and receptive field density and spatial summation, 
derived from an analysis of 8 healthy subjects, was incorporated into the model.  
The results of this study indicated that proportionally greater RGC loss is 
needed in the central compared to peripheral field for a similar change in DLS, 
and that the relationship between DLS and RGC density adjusted for local spatial 
summation is linear when sensitivity is converted from logarithmic to linear units. 
The coefficients from the linear regression of SAP sensitivity against RGC density 
could be used to estimate RGC density as follows: 
RGC density = [(DLS +392) / 208]1/k 
Where k = the location-specific spatial summation value, ranging from 0 
near the fovea to 1 in the periphery, and DLS is the differential light sensitivity in 
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1/Lambert (dB = 10 × log10 (1/Lambert)).  A major strength of this model is that is 
accounts for spatial summation, however the model only accounts for location-
specific changes in spatial summation and not changes that occur due to 
glaucomatous RGC loss.   
2.4.6. Hockey-Stick model 
Swanson and colleagues used the same normative data (Curcio, & Allen 
1990; Heijl et al 1987)  as Garway-Heath to examine the relationship between 
SAP sensitivity and RGC density and developed a Hockey-Stick model, which is 
attractive as it acknowledges that the relationship between RGC number and 
sensitivity varies during the course of disease, and considers variation in spatial 
summation with eccentricity (Swanson et al 2004).  
The relationship between SAP sensitivity and RGC receptive field density was 
modelled with a breakpoint occurring at 15-degree eccentricity to account for the 
change from probability summation to complete spatial summation in healthy 
subjects (section 2.4.1, page 62). The relationship between SAP sensitivity and 
RGC density was linear, with a slope of one at locations with greater than 15-
degree eccentricity (region of complete spatial summation), and a shallower 
slope at locations with 15-degree eccentricity (region of probability summation) 
(Figure 2-10). 
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Figure 2-10. Scatter plot for normative data for the size III stimulus derived from 
Heijl et al (Heijl et al 1987) and Curcio et al (Curcio, & Allen 1990) and adapted from 
Swanson et al (Swanson et al 2004), fitted to the two-parameter spatial summation 
function.  Points to the left of the of the figure represent locations at eccentricities 
of greater than 15 degrees, compared to points to the right of the curve at 
eccentricities of less than 15 degrees. 
 
The change in slope can be explained by the size of the Goldmann size III 
stimulus in relation to the critical area of spatial summation (Ricco’s area) 
(Redmond et al 2010). In healthy eyes the Goldmann size III stimulus is larger 
than the critical area at eccentricities of 15-degrees or less and smaller than the 
critical area at locations closer to the fovea. The breakpoint corresponds to a 
sensitivity of approximately 31.5 dB (Swanson et al 2004). In glaucoma, the size 
of the critical area enlarges with loss of RGCs, therefore more SAP test locations 
will fall to the left of the breakpoint (Figure 2-10).  
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2.4.7. Hood-Kardon model 
 The Hood-Kardon structure-function model is another model proposed as a 
method to relate OCT RNFL thickness to SAP measurements in decibels (Hood, 
& Kardon 2007). DLS values from each SAP test location are converted to linear 
units, which are then averaged and compared to global RNFL thickness. The 
model proposes that RNFL thickness is composed of 2 components, RGC axons 
and a residual thickness consisting of blood vessels and glial cells. The model 
also proposes decreases in DLS are accompanied by decrease in the RGC 
component but that the residual thickness does not change. This is contrary to 
the model of Harwerth and colleagues, which assumes that there is actually an 
increase in the residual thickness with loss of RNFL over time (Harwerth et al 
2010). The Hood-Kardon model is summarised by the equation: 
RNFL thickness = s0 x 100.1x D + b (if D ≥ 0) 
RNFL thickness = s0 + b (if D ≥ 0) 
where s0 is the thickness of the RGC component, or signal, D is the loss of 
visual sensitivity on the decibel scale, and b is the residual thickness or base 
level. The authors estimated the base level from an analysis of eyes with 
severely depressed DLS due to anterior ischemic optic neuropathy. An 
interesting feature of this model is that it assumes that the relationship between 
RNFL thickness and SAP sensitivity is only significant in eyes with abnormal 
sensitivity (i.e., there is no relationship between RNFL thickness and SAP 
sensitivity in healthy eyes).  
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2.4.8. Drasdo model 
 The Drasdo model has been proposed as an alternative method of 
quantifying RGC loss from perimetric data (Drasdo et al 2008). The model 
considers increased RGC density in the central field, as well as the lateral 
displacement of RGC bodies from foveal cones (Drasdo et al 2007). RGC density 
corresponding to each of the 24-2 SAP test points was estimated. Similarly, to 
the other models, normative SAP data was obtained from the work of Heijl and 
colleagues, therefore for a healthy subject with a mean age of 34 years (Heijl et 
al 1987). RGC counts were assumed to decline by 0.59% per year, increasing to 
0.79% at age 76 years, which translates to a loss of about 6,500 cells per year as 
described by Curcio and Drucker (Curcio, & Drucker 1993). Expected RGC 
density for any age above 34 years was then estimated using the formula: 
RGC density at age ‘a’ = RGC density at age 34* {1-[(a – 34)/169]} 
Age-expected SAP sensitivity was obtained using the method of point-wise 
age regression described by Heijl et al (Heijl et al 1987). Figure 2-11 shows an 
example of this analysis for a healthy 60-year-old subject. 
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Figure 2-11. Estimated RGC receptive field densities (D) and SAP sensitivities (S) 
for the right eye of a healthy 60-year-old subject. SAP sensitivity is displayed in 
bold as 1/Lambert units. Adapted from Drasdo et al 2008 (Drasdo et al 2008).  
 
For eyes with glaucoma, Drasdo proposed a two-stage model, similar to the 
Hockey-Stick model (section 2.4.6, page 71), with a linear relationship between 
DLS and numbers of RGCs at locations with low DLS and a shallower 
relationship at locations with high DLS. 
 
2.4.9. Zhu model 
Recently Zhu and colleagues have recently described a novel method of 
predicting DLS from RNFL thickness using a type of neural network known as a 
Bayesian radial basis function (BRBF) (Zhu et al 2010). Classic linear regression 
analysis makes several incorrect assumptions about data, including an 
assumption that the relationship between RNFL thickness and DLS is linear or 
becomes linear after a transformation.  In practice, the relationship between 
RNFL thickness and VF sensitivity is likely to change at difference stages of 
disease (or across the measurement range). Moreover, linear regression is 
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affected by outliers and assumes each RNFL value is independent of all other 
RNFL values, whereas in reality neighbouring RNFL values are topographically 
related. BRBF acts like a dynamic window that moves across the data spatially 
and at different disease stages, identifying groups of measurements that behave 
in a similar manner and improving predictions of DLS. The model provided a 
means to present structural information in the domain of the visual field and was 
found to predict DLS from RNFL thickness almost as well as another SAP test 
from the same patient. 
 
2.4.10. Limitations of the models 
Although each of the structure-function models provide insight into the 
relationship between glaucomatous structural changes (RNFL or RGC loss), and 
changes on SAP, they have limitations. For example, the Garway-Heath, Hockey-
Stick and Drasdo models are all based on data obtained from histology of only 6 
eyes from 5 young subjects, aged only 27 to 37 years (Curcio, & Allen 1990). The 
Harwerth model was derived from a much larger number of eyes, but from an 
animal model, with results extrapolated to humans (Harwerth et al 2010).  
Furthermore, close examination of previous studies shows that there is wide 
variation in SAP sensitivity for a given RGC density and many of the perimetric 
test locations with reduced sensitivity had normal RGC counts (Harwerth et al 
2010; Kerrigan-Baumrind et al 2000; Malik et al 2012). Therefore, although, on 
average, estimates of RGC count from DLS may be accurate, estimates for 
individual patients may not. This is particularly true in healthy subjects, where 
variation in RGC counts and RNFL thickness is large.  
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A further limitation of the models is that although they attempt to relate 
changes in RNFL thickness to loss of SAP sensitivity, clinical studies have shown 
that the temporal relationship between structural and functional changes is 
imperfect (Kass et al 2002). RGCs may become dysfunctional without detectable 
changes to RNFL thickness, with the result that some patients may exhibit loss of 
SAP sensitivity without change on RNFL (Fortune et al 2013a), whereas others 
may have changes in RNFL prior to changes in SAP (section 2.3, page 51). 
Changes in RNFL thickness can also be caused by RGC shrinkage rather than 
frank loss of cells (Morgan 2002) and the RNFL may increase in thickness with 
surgical reduction of IOP (Aydin et al 2003). Agreement between structure and 
functional domains will also be affected by the choice of technology used; for 
example, SAP 24-2 has sparse sampling of the central field, which may reduce 
the strength of the structure-function correlation. Although some of the models 
consider non-neural components of the RNFL, one assumes this component 
does not change with disease progression (Hood-Kardon model) (Malik et al 
2012).  
Harwerth’s model has some specific and serious limitations that should be 
emphasised. For example, although the model considers changes in RGC 
density at different eccentricities, it does not account for lateral displacement of 
foveal RGCs or changes in Ricco’s area. Some of the effect of changes in 
Ricco’s area is accounted for by correction for RGC density by eccentricity but 
the model does not account for changes in Ricco’s area that occur with disease 
(section 2.4.1, page 62) (Redmond et al 2010). Due to the centre surround 
organization of receptive fields the influence of a RGC extends beyond its 
receptive field and with probability summation a single ganglion cell will contribute 
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little to the overall threshold response. Furthermore, Swanson and colleagues 
have recently highlighted that the OCT-derived RGC estimates assumes a mean 
RGC axon diameter of 0.9 μm, whereas the actual mean axon diameter is 0.5 to 
0.7 μm (Swanson, & Horner 2015). This miscalculation results in OCT-derived 
estimates of RGC to be consistently lower than estimates derived from SAP and 
even this is a simplification as the diameter of RGC axons varies between axons 
and along the length of the same axon. RGCs have bulb shaped varicosities 
along their course, which are rich in mitochondria and in some instances these 
locations are 5 to 10 times larger than the diameter of the axon in the inter-bulb 
region (Wang et al 2003); a variation that may affect estimates of RGC count 
based on RNFL thickness measurements. In addition, there are 10 to 15 different 
types of RGC, each with different axonal and receptive field size (Dacey, & Lee 
1994). Harwerth’s model makes other unproven assumptions. For example, it is 
not clear from published data how the correction factor, c, was derived. Although 
it is proposed to correct for remodelling of the RNFL with advancing disease, 
remodelling of the RNFL is complex and has not been adequately quantified 
histologically. The correction factor for RGC estimates from RNFL may have 
been introduced to better fit RGC estimates from SAP and OCT, and later 
explained by remodelling.  
It is also important to acknowledge that although structure function models 
strive to explain the relationship between glaucomatous structural changes and 
changes to visual function, there is unlikely to be a perfect relationship between 
structure and function. There is accumulating evidence, for example from 
Jonathan Crowston’s group in Melbourne, that RGCs have the potential to 
recover some functional loss (Crowston et al 2017). Therefore, a sick RGC may 
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have impaired function but apparently normal structure on imaging, creating a 
disparity between structural and functional tests.  
 
2.4.11. Integrating structural and functional measurements 
The disparity between structural and functional tests means that we are likely 
to always need methods of assessing both domains. There has therefore been 
much interest in how to best integrate results from these tests in order to 
maximize the diagnostic and staging capabilities of available tests (Medeiros et al 
2012; Russell et al 2012). At present, clinicians already integrate results as they 
intuitively combine information to decide if a patient is progressing.  However, this 
approach is subjective and made difficult by the different measurement scales of 
devices.  
Russell and colleagues have described how Bayesian mathematics can be 
used to incorporate information about rate of change in neuroretinal rim over time 
to improve estimates regarding rates of change in visual field and therefore better 
predict those at risk of visual loss (Russell et al 2012). A similar method could 
also be used to incorporate information about demographic and clinical risk 
factors as priors.  
Another approach of combining information from structural and functional 
tests is the combined structure function index (CSFI) described by Medeiros at 
UCSD (Medeiros et al 2012). The CSFI is based on the formulae developed by 
Harwerth and colleagues described in section 2.4.4, page 66 and is an estimate 
of the percentage of RGCs lost compared to that expected for a healthy subject 
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of similar age. The CSFI combines the RGC estimates derived from OCT and 
SAP measurements, with a weighting that assigns greater emphasis to RGC 
estimates from OCT in early disease, and greater emphasis to estimates from 
SAP in advanced disease based on the evidence that accuracies of SAP and 
imaging tests are inversely related to disease severity. Medeiros proposed 
combining the estimates of RGC count from SAP (SAPrgc) and OCT (OCTrgc) 
using the formula: 
Estimated RGC count = (1 + MD/30)*OCTrgc + (-MD/30)*SAPrgc 
Where MD is the SAP MD. Medeiros estimated RGC counts in healthy 
eyes using the same formula and from this calculated an estimate of the 
percentage of RGCs an eye has lost compared to that expected for a healthy 
age-matched individual (Medeiros et al 2012). The CSFI was then calculated 
using the following formula: 
CSFI = [(expected RGC count – estimated RGC count)/(expected RGC 
count)]*100 
The CSFI has the advantage of providing an intuitive unit of measurement 
compared to Bayesian methods of integrating structure and function, and it has 
been shown to have good ability to distinguish healthy and glaucomatous eyes at 
all stages of disease, including in eyes with preperimetric glaucoma (Medeiros et 
al 2012). Moreover, by combining information from structural and functional tests 
it may reduce the effect of variability inherent in each test and obtain more 
accurate estimates of RGC number. The CSFI is however limited by the 
weakness inherent in Harwerth’s formulae (section 2.4.10, page 76). Although 
the CSFI relies on primarily RNFL in early disease and SAP in advanced disease, 
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Swanson has recently shown that the Harwerth RNFL formula over-estimate 
neural loss compared to the Harwerth SAP formula at all stages of disease 
(Swanson, & Horner 2015). Therefore, it is likely that the CSFI underestimates 
RGC number in early disease compared to RGC estimates in late disease. 
However, despite these limitations the CSFI is currently the only index to provide 
an estimate of RGC loss compared to numbers expected for a healthy age-
matched individual. 
 
In summary, structure-function models broadly adopt one of two 
approaches; either they attempt to directly quantify the relationship between loss 
of RNFL and SAP sensitivity (Hood-Kardon model), or they relate these changes 
to estimated underlying loss of RGCs (Harwerth model, Swanson model, Drasdo 
model). The models provide evidence that structural and functional 
measurements are related, suggesting that structural changes are a clinically 
relevant surrogate for functional losses in glaucoma. However, the models are 
based on cross-sectional data and do not fully address the longitudinal 
relationship between structural changes and visual loss. In addition, large clinical 
studies have shown that disagreement between structure and function is 
common, something not addressed in structure-function models (section 2.3, 
page 51) (Kass et al 2002) Reasons for disagreement include differences in 
dynamic range and measurements scale, however, there is also growing 
evidence that RGCs may show some recovery with glaucoma treatment, 
indicating that RGCs may become dysfunctional prior to apoptosis and 
measurable permanent structural change. Disparity between structure and 
function should therefore be expected and for optimal detection of glaucoma and 
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glaucoma progression we need to continue to test both structural and functional 
domains. Combining information from structural and functional tests may also be 
useful for better understanding of how glaucoma affects important patient-
relevant functional endpoints, such as the ability to perform vision-related tasks of 
daily living, however, there is a lack of research in this area.  Also, while the 
implications of a detectable loss of visual field are obvious for the patient, that is 
not so much the case for structural changes such as thinning of the RNFL or 
neuroretinal rim (Medeiros et al 2016). Clinical studies have shown that 
progressive glaucomatous structural changes are associated with increased risk 
of visual loss but it is important to demonstrate that progressive structural 
changes are predictive of outcomes that are clinically relevant for patients. The 
aim of this body of work was to explore the structure-function relationship and to 
ascertain the point at which structural changes become associated with impaired 
ability to perform vision-dependent tasks. The following section of this thesis 
outlines the materials and methods of this research project. 
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3 SECTION III: MATERIALS AND METHODS 
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3.1. Hamilton Glaucoma Center 
Most the work for this project was conducted at the HGC at UCSD working 
under the supervision of Dr Robert Weinreb, Dr Felipe Medeiros and Dr Linda 
Zangwill. Patients were recruited from two large on-going prospective longitudinal 
studies; the African Descent and Glaucoma Evaluation Study (ADAGES) and the 
Diagnostic Innovations in Glaucoma Study (DIGS) (Sample et al 2009). ADAGES 
is a 3-site collaboration including HGC at the Department of Ophthalmology, 
UCSD (data coordinating centre), the New York Eye and Ear Infirmary, and the 
Department of Ophthalmology, University of Alabama, Birmingham (UAB). The 
DIGS includes only patients recruited at UCSD and the protocol is identical to 
that of the ADAGES. Data are centrally processed and analysed at UCSD 
through established reading centres.  The institutional review boards at all 3 sites 
approved the study methods for ADAGES and the institutional review board at 
UCSD approved the methods for DIGS and for the current body of work. Study 
methods adhered to the tenets of the Declaration of Helsinki and all participants 
gave written informed consent. Normal and patient participants were recruited 
from the glaucoma clinics and optometric practices at each of the 3 recruiting 
sites, by advertisement and community presentations, and by referral from other 
ophthalmologists. 
3.2. Testing Protocol 
At each visit, subjects underwent a comprehensive eye examination 
including relevant medical history, blood pressure measurement, best-corrected 
visual acuity, slit-lamp biomicroscopy, gonioscopy, Goldmann applanation 
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tonometry, central corneal thickness measurement, dilated fundoscopy, 
stereoscopic ophthalmoscopy of the optic disc with a 78-diopter lens, and 
simultaneous stereoscopic disc photography. Central corneal thickness (CCT) 
was calculated as the average of three measurements obtained during the same 
visit using an ultrasound pachymeter (Pachette GDH 500; DGH Technology, Inc, 
Philadelphia, PA, USA). Digital stereoscopic images were reviewed with a 
stereoscopic viewer (Screen-VU stereoscope, PS Mfg., Portland, Oregon, USA) 
by two or more experienced graders, with each grader masked to the subject's 
identity and to the other test results. SAP was obtained using the Humphrey Field 
Analyzer II (Carl Zeiss Meditec, Dublin, CA, USA) and the 24-2 Swedish 
Interactive Threshold Algorithm strategy. All subjects also had ONH and RNFL 
imaging using Cirrus SDOCT (software version 6.0; Carl Zeiss Meditec Inc, 
Dublin, CA), Spectralis SDOCT (Heidelberg Engineering, Dossenheim, 
Germany).  Consecutive series of subjects participating in the DIGS and 
ADAGES had additional tests for the current body of work. This included testing 
with automated pupillometry (section 4.3, page 114) and performing a simulated 
driving task (section 4.4, page 137). These additional tests are described in detail 
in the relevant sections of this thesis.  
3.2.1. Inclusion criteria 
For inclusion in the study, all subjects were required to have open angles 
on gonioscopy, a best-corrected visual acuity of 20/40 or better, and refraction 
less than 5.0 dioptres sphere and 3.0 dioptres cylinder. All participants were older 
than 18 years. Diabetic participants with no evidence of retinal involvement were 
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included. Subjects were required to have at least one good quality 
stereophotograph and one reliable SAP result.  
3.2.2. Exclusion criteria 
Subjects were excluded if they presented with a best-corrected visual 
acuity of less than 20/40, spherical refraction outside ±5.0 dioptres and/or 
cylinder correction outside 3.0 dioptres, or any other ocular or systemic disease 
that could affect the optic nerve or the visual field. They were also excluded if 
they had a history of intraocular surgery (except for uncomplicated cataract or 
glaucoma surgery); secondary causes of glaucoma (e.g., iridocyclitis, trauma); 
other systemic or ocular diseases known to affect the visual field (e.g., pituitary 
lesions, demyelinating diseases); significant cognitive impairment; history of 
stroke, Alzheimer disease, or dementia or problems other than glaucoma 
affecting colour vision.  
3.2.3. Optical coherence tomography 
Measurements of cpRNFL were obtained using two SDOCT devices; 
Cirrus SDOCT (software version 6.0; Carl Zeiss Meditec, Inc, Dublin, CA) and 
Spectralis SDOCT (software version 5.4.7.0; Heidelberg Engineering, 
Dossenheim, Germany). The Spectralis OCT uses a dual-beam SDOCT and a 
CSLO that works by emitting a superluminescent diode light with a centre 
wavelength of 870 nm and another infrared scan to simultaneously provide 
images of ocular microstructures. A real-time eye tracking system is incorporated 
that couples CSLO and SDOCT scanners to adjust for eye movements and to 
ensure that the same location of the retina is scanned over time. 1536 A-scan 
points were acquired from a 3.45-mm circle centred on the optic disc. Spectralis 
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SDOCT images were reviewed by the UCSD Imaging Data Evaluation and 
Analysis Centre to ensure the scan was centred, that the signal strength was 
>15dB and that there were no artefacts. Scans that were inverted, clipped or 
those that had coexistent retinal pathological abnormalities were excluded. The 
RNFL segmentation algorithm was also checked for errors.  
The Cirrus SDOCT uses a superluminescent diode scan with a centre 
wavelength of 840 nm and an acquisition rate of 27,000 A-scans per second. The 
optic disc cube 200 x 200 protocol was used to acquire RNFL thickness 
measurements. This protocol is based on a 3-dimensional scan of a 6 × 6 mm 
area centred on the optic disc in which information from a 1024 
(depth) × 200 × 200 point parallelepiped is collected. The cpRNFL thickness 
measurements from Cirrus were calculated from a 3.46-mm diameter circular 
scan (10.87-mm length) automatically placed around the optic disc. The reported 
average RNFL thickness corresponded to the 360-degree measure automatically 
calculated by the OCT software. The Cirrus SDOCT images were also reviewed 
by the UCSD Imaging Data Evaluation and Analysis Centre and included if the 
signal strength was greater than 7, if movement artefacts were absent, and there 
was good centring on the optic disc.  
3.2.4. Standard automated perimetry 
SAP was performed using the Humphrey Field Analyzer II (Carl Zeiss 
Meditec, Dublin, CA, USA) and all fields were evaluated by the UCSD Visual 
Field Assessment Centre. Visual fields with more than 33% fixation losses or 
false-negative errors, or more than 15% false-positive errors, were excluded. The 
only exception was the inclusion of visual fields with false-negative errors of more 
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than 33% when the field showed advanced disease. Visual fields exhibiting a 
learning effect (i.e., initial tests showing consistent improvement on visual field 
indices) were also excluded. Visual fields were further reviewed for the eyelid and 
rim artefacts, fatigue effects, inappropriate fixation and evidence that the visual 
field results were caused by a disease other than glaucoma. An abnormal SAP 
test was defined as a visual field with a pattern standard deviation with P <0.05 
and/or a Glaucoma Hemifield Test outside normal limits.  
3.3. Study Definitions  
Participants were defined depending on the diagnosis in their worse eye 
as healthy or glaucomatous. Glaucoma was defined by the presence of three or 
more consecutive abnormal SAP tests or evidence of progressive glaucomatous 
optic disc changes based on masked assessment of stereophotographs. 
Glaucomatous optic disc damage was defined as evidence of excavation, 
neuroretinal rim narrowing or notching, localized or diffuse RNFL defect, or a 
between-eye asymmetry of the vertical cup-disc ratio more than 0.2. Suspect 
glaucoma was defined by the presence of suspicious neuroretinal rim narrowing 
or RNFL defects on masked stereophotograph assessment, without repeatable 
abnormal SAP defects. OHT was defined as eyes with IOP > 21 mmHg but with 
healthy-appearing optic discs and without repeatable abnormal SAP results. 
Healthy subjects were recruited from the general population through 
advertisements and from the staff and employees of UCSD. Healthy eyes were 
required to have IOP ≤ 21 mmHg with no history of increased IOP and normal 
SAP.  
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3.4. Statistical Methods 
The statistical methods used for each part of my research are described in 
detail in the relevant sections, however in brief; normality assumption was 
assessed by inspection of histograms and using Shapiro-Wilk tests. Descriptive 
statistics included mean and standard deviation for normally distributed variables, 
and median, first-quartile and third-quartile values for non-normally distributed 
variables. Student t-tests were used for group comparison for normally distributed 
variables and Wilcoxon rank-sum test for continuous non-normal variables. For 
categorical variables, X2 tests or Fisher exact tests were used. All statistical 
analyses were performed with commercially available software (STATA, version 
12; StataCorp LP, College Station, TX, USA). The α level (type I error) was set at 
0.05. The following section outlines the aims and plan of the research.  
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4 SECTION IV: EXPERIMENTS 
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4.1. Aims and Plan of Research 
Structural parameters such as measurements of RNFL thickness from OCT 
are widely used to detect glaucoma and quantify rates of progression, however 
the true relevance of these measurements remains poorly understood. For 
example, it is not known at which point structural changes become associated 
with decreased ability to perform vision-dependent tasks of daily living. 
Furthermore, it is not known whether information from structural tests may 
provide additional information compared to conventional measures of visual 
function for predicting the impact of glaucoma on ability to perform such tasks. 
Improved understanding of the relationship between structural and functional 
changes could provide further validation for the use of structural measures as a 
clinically relevant parameter in glaucoma management. The aim of my MD(Res) 
was to explore the relationship between glaucomatous structural changes and 
measures of visual function. The body of work was divided into three parts. 
1. In part 1 (section 4.2, page 94) I examine the relationship between 
structural and functional changes by examining estimated RGC losses in 
eyes with localised loss of the RNFL (Tatham et al 2013). Localised RNFL 
losses are often considered an early manifestation of glaucomatous 
structural damage, however I hypothesised that they might be associated 
with large underlying RGC losses. I identified eyes with localised RNFL 
defects on stereophotographs and estimated corresponding RGC losses in 
involved sectors using formulae proposed by Harwerth and colleagues 
(Harwerth et al 2010) and modified by Medeiros and colleagues (Medeiros 
et al 2012), described in detail in section 2.4.4, page 66 and section 2.4.11, 
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page 79. Although I found localised RNFL defects visible on photographs 
were associated with large estimated RGC loss, through this phase of my 
studies I discovered serious flaws in the assumptions of the model used to 
estimate RGC counts, which are discussed in this section.  
2. Part 2 of my research (section 4.3, page 114) was to examine the 
relationship between glaucomatous structural loss and an objective 
measure of visual function related to RGC integrity – the pupillary light 
response (Tatham et al 2014b). Although previous investigators have 
examined the relationship between structural changes and DLS, little is 
known about the correlation between glaucomatous structural changes and 
pupil responses. The pupil response is a rapid, objective method of 
assessing the afferent visual pathway. Pupil responses were assessed 
using an automated pupillometer and the magnitude of pupil response 
asymmetry compared to inter-eye differences in RNFL thickness and SAP 
MD.  
3. The final part of this body of work (section 4.4, page 137) examines the 
relationship between glaucomatous structural loss and the ability to perform 
a vision-related performance-based task related to activities of daily living 
(Tatham et al 2014a). Driving is an important activity of daily living for many 
patients with glaucoma and arguably a performance-based test, such as 
ability to drive, may be of more relevance to quality of life, than traditional 
tests of visual function such as SAP. It is therefore important to understand 
the relationship between glaucomatous structural changes and ability to 
perform tasks such as driving. This section also explores whether including 
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information from OCT might improve the ability to predict driving 
performance compared to perimetry alone. 
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4.2. The relationship between localised RNFL loss 
and estimated loss of RGCs  
4.2.1. Background 
A common structural manifestation of glaucoma visible on dilated fundus 
examination is the localised RNFL defect, often considered to occur early during 
disease (Quigley 1986). In fact, several tools used for glaucoma detection focus 
on detecting localised changes, typical of glaucoma, for example, the visual field 
indices GHT and PSD.  For this section of my research I decided to examine the 
relationship between localized RNFL defects and estimated numbers of RGCs, to 
determine whether localised RNFL defects are indeed an early feature of 
glaucoma. As the number of RGCs is directly related to visual function and the 
prognosis for retaining useful vision, I also hoped this analysis would provide 
some insight into the relevance of localised RNFL loss for patients.  
As RGC loss cannot be measured in vivo directly I decided to estimate RGC 
loss from observed structural and functional changes.  After considering the 
methods of estimating RGC loss appraised in section 2.4, page 62 I opted to 
estimate RGC loss using the CSFI suggested by Medeiros from formulae 
developed by Harwerth and colleagues (Harwerth et al 2010; Medeiros et al 
2012). Although the CSFI has limitations, discussed in detail in sections 2.4.10, 
page 76, and 2.4.11, page 79, were the formulae accurate it would provide an 
attractive method of estimating the percentage of RGCs lost compared to that 
expected for a healthy eye from a similar aged individual and it is currently the 
only model designed for this purpose. 
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The CSFI was developed as a global index, however, as eyes with localised 
RNFL defects may have relative preserved RNFL in sectors outside the visible 
defect, a global index may fail to reflect the depth of localised loss.  This is often 
apparent on OCT cpRNFL analysis, when compared to the normative database, 
the global average cpRNFL thickness may be classified as normal despite one 
sector being abnormal. To estimate RGC losses in the region of a visible 
localised RNFL defect I needed to modify the global CSFI to obtain a sector 
CSFI. As the estimate of RGC numbers is obtained from information from OCT 
and SAP it was important not to use information from these instruments when 
identifying patients and the location of structural losses. I decided to identify 
patients by reviewing the library of stereophotograph images from patients 
involved in the DIGS at UCSD. All patients with a localised RNFL defect visible 
on stereophotographs were identified and further examined as outlined in the 
methods (4.2.3). 
In healthy eyes the RNFL has a bright, striated appearance, and is most 
readily identifiable close to the superior and inferior poles of the optic disc where 
the RNFL is thickest (Quigley 1986).  RNFL striations are due to bundles of RGC 
axons separated by Muller cell processes, with the bright component the highly 
reflective parallel RGC axon bundles and the dark component the thick non-
reflective dividing Muller cell glial septa (Radius, & Anderson 1979). RGC axonal 
loss leads to a reduction in the reflectivity of RGC axon bundles. Diffuse loss 
leads to a darkened appearance to the inner retina and increased visibility of 
blood vessels, whereas localised RNFL defects tend to be wedge-shaped with 
sharply demarcated borders narrowing towards the disc margin as the RNFL 
bundles converge. Localised RNFL defects may be associated with non-
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glaucomatous conditions, including other optic neuropathies or optic disc drusen, 
however, they have high specificity for glaucoma and are not found in healthy 
eyes (Jonas, & Schiro 1994b; Jonas, & Schiro 1994a). 
Although localised RNFL defects are traditionally viewed as an early sign of 
glaucomatous damage (Sommer et al 1991; Quigley 1986), a previous primate 
study found that a localized RNFL defect was only apparent on fundus 
photographs if more than 50% of the thickness of the RNFL had been lost 
(Quigley, & Addicks 1982). A second study, including human eyes also found 
large neural losses with localized loss of 28 to 45% of RNFL thickness in areas 
corresponding to visible RNFL defects (Quigley 1986). 
4.2.2. Purpose 
The purpose of this phase of my research was to estimate the percentage of 
RGC loss in eyes with localised RNFL defects visible on stereophotographs. I 
modified the CSFI to obtain a sectorial estimate of RGC loss, which could be 
related to regions of RNFL loss visible on stereophotographs. Estimates of RGC 
loss in sectors with a visible RNFL defect were compared to estimates of RGC 
numbers in areas without a visible RNFL defect and to estimates in healthy eyes.  
4.2.3. Methods 
This phase of my research included 264 eyes of 193 individuals recruited 
from the DIGS at UCSD. There were 66 eyes of 55 subjects with glaucoma and 
localised RNFL defects visible on fundus stereophotographs and 198 eyes of 138 
healthy subjects. All subjects underwent testing as described in section 3.2, page 
84. Localised RNFL defects, identified by at least 2 graders, were defined as 
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defects wider than twice the width of an arteriole, extending from close to the disc 
margin into the parapapillary area, widening en route (i.e., wedge-shaped) 
(Quigley 1986).  Slit defects narrower than the diameter of adjacent vessels were 
not included as they are frequently found in normal eyes (Jonas, & Schiro 
1994b). 
Estimating sectorial RGC loss 
 The CSFI involves estimating RGC loss from RNFL and SAP 
measurements, and combining the estimates, with a weighting to account for 
disease severity (Sector 2.4.11) (Medeiros et al 2012). To estimate localised 
RGC loss, it was necessary to use a structure-function map to relate RNFL 
thickness to corresponding SAP sensitivities. Several structure function maps 
have been described (Wirtschafter et al 1982; Weber et al 1990; Yamagishi et al 
1997; Anton et al 1998; Garway-Heath et al 2000; Garway-Heath et al 2002; 
Harwerth et al 2010), the foremost of which is the Garway-Heath map (Garway-
Heath et al 2000). The Garway-Heath map was derived from examination of 69 
eyes with well-defined localised RNFL defects or prominent RNFL bundles. A 
scaled Humphrey 24-2 visual field and ONH reference circle was superimposed 
onto fundus photographs for these eyes and the visual field test points related to 
regions of the ONH (Figure 4-1). The map divides the ONH into 6 sectors, with 3 
regions of the visual field corresponding to the nasal half of the ONH falling 
largely outside the region of the 24-2 field. The central region of the visual field is 
associated with the temporal sector of the ONH from 311 to 40 degrees, the 
superior arcuate region of the field is associated with the inferior temporal ONH 
from 271 to 310 degrees, and the inferior arcuate region of the field is associated 
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with the superior temporal sector from 41 to 80 degrees. The map has 
subsequently been shown to be a good predictor of correlation between DLS and 
quantitative measurements of RNFL thickness obtained using OCT (Ferreras et 
al 2008) and a slightly modified version of the map was published in 2002 with 
the ONH divided into sectors to match the divisions on CSLO (Garway-Heath et 
al 2002). 
Figure 4-1. Garway-Heath et al structure-function map showing division of the 
visual field and optic nerve head (A) with the regions of the RNFL profile that 
correspond to the superior (blue) and inferior (red) temporal arcuate fibres. 
Adapted from (Garway-Heath et al 2000) and (Hood, & Kardon 2007). 
  
The Harwerth map was developed following studies in nonhuman primates 
described in section 2.4.4, page 66 (Harwerth et al 2007).  The map was 
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designed to maximise correlation between estimates of RGC number derived 
from SAP sensitivities and measurements of RNFL thickness on OCT. The final 
map involved dividing the ONH into 10 equal 36-degree sectors (Figure 4-2) 
(Harwerth et al 2007). The number of SAP locations assigned to each ONH 
sector varied from one SAP location near the fovea (entering the ONH at sector 1 
or 10) to 13 SAP locations for the arcuate regions (entering the ONH at sectors 4 
or 7).  
Figure 4-2. Harwerth structure function map showing 10 sectors of the visual field 
and 10 corresponding ONH sectors (Harwerth et al 2007).  
 
Using the Harwerth map, I planned to estimate the number of RGCs in each 
of the 10 sectors and then relate these estimates to the location of the visible 
RNFL defects. All subjects had cpRNFL thickness measured using Spectralis 
OCT, which provides 1,536 A-scan points from a 3.45mm circle scan. The 
average cpRNFL thickness in each of the sectors was calculated by taking the 
average of 154 adjacent A-scans for each of sectors 1 to 6, and the average of 
153 adjacent A-scans for sectors 7 to 10. The number of RGC axons in each 
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sector was estimated using the following formula adapted from Harwerth and 
colleagues’ original formula (Harwerth et al 2010) (section 2.4.4, page 66). 
d = (-0.007*age) + 1.4 
c = (-0.26*sMD) + 0.12 
sector OCTrgc = 10^({[log10(sector RNFL*10870*d)]*10 - c}*0.1) 
Where d is the axonal density (axons/μm2), c is a correction factor for the 
severity of disease to consider remodelling of RNFL axonal and non-axonal 
composition, sMD is the sector mean deviation and sector OCTrgc is the 
estimated number of RGC axons in the sector. sMD was calculated by measuring 
the deviation of the SAP sensitivity from the expected sensitivity of SAP test 
locations in each sector. Expected values were derived from the SITA normative 
database using the method described by Harwerth and colleagues (Table 4-1) 
(Harwerth et al 2010). sMD was calculated as the geometric mean by converting 
logarithmic values from each visual test location to linear values prior to 
averaging. 
Table 4-1. Predicted mean visual field sensitivities for healthy eyes in each of the 
10 sectors of Harwerth and colleagues structure function map (Harwerth et al 
2010). 
Sector 
Number 
1 2 3 4 5 6 7 8 9 10 
Slope 
(dB/year) 
-0.057 -0.061 -0.060 -0.062 -0.057 -0.057 -0.061 -0.057 -0.062 -0.060 
Intercept 
(dB) 
34.68 33.60 33.32 31.68 31.68 31.68 31.19 33.46 33.01 34.45 
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The numbers of RGCs was also estimated from SAP sensitivities at the 
test locations corresponding to each sector using the formulae previously 
described in section 2.4.4, page 66, to obtain sector SAPrgc estimates. A 
combined structure-function estimate of RGC numbers (weighted RGC count, 
wrgc) was then calculated by averaging OCTrgc and SAPrgc using the weighting 
described by Medeiros (Medeiros et al 2012) (section 2.4.11, page 79), assigning 
relatively greater value to OCT in early disease and to SAP in more advanced 
disease. 
sector wrgc = (1 + sMD/30)*sector OCTrgc + (-sMD /30)*sector SAPrgc 
I then calculated an estimate of percentage of RGC loss in each sector 
compared to that expected for a healthy eye of similar age – the sector CSFI, like 
the global CSFI previously described by Medeiros and colleagues (Medeiros et al 
2012).  
To estimate sector RGC counts in healthy eyes I used a development 
sample of 169 healthy eyes recruited from the general population, involved in the 
DIGS. The inclusion criteria for healthy subjects has been detailed elsewhere in 
this thesis (section 3.3, page 88). Numbers of RGCs were estimated for each 
sector of the structure-function map and 10 regression models developed (one 
for each sector) to relate estimated numbers of RGCs to age and optic disc area, 
which have been shown to influence RGC numbers (Harwerth et al 2010). To 
avoid model over fitting none of the eyes in the development sample were 
included in the subsequent analysis. The sector CSFI was then calculated as an 
estimate of the percentage of RGCs lost in each sector using the formula: 
Sector CSFI = [(expected number of RGCs in sector - sector wrgc) / 
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(expected number of RGCs in sector)]*100 
The location of the RNFL defect was determined from optic disc 
stereophotographs by superimposing a 10-segment (36-degree) circle, 
corresponding to the 10 zones of the structure function map (Figure 4-3). The 
circumference of the 10-segment circle was manually adjusted for best possible 
fit to the margin of the optic disc using image processing software (GNU Image 
Manipulation Program, 2.8.18, https://www.gimp.org). The ONH sectors of the 
structure-function map corresponding to the visible RNFL defect were noted with 
the defect deemed to affect all sectors that it straddled. Left eyes were 
transposed horizontally to a right eye position so that the 9 o’clock sector 
represented the inferior-temporal ONH in all eyes. 
Figure 4-3. Example of an eye included in the study with a localised RNFL defect 
(arrows). The location of the RNFL defect was determined by superimposing a 10-
segment circle on the ONH image, corresponding to the 10 zones of Harwerth’s 
structure function map. In this example, the visible RNFL defect is in sector 8.  
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Statistical Analysis 
Descriptive statistics were performed according to the methods described 
in section 3.4, page 89. The sector CSFI in sectors with localised RNFL defects 
was compared to the sector CSFI in sectors without defects in patients with 
glaucoma and healthy controls.  
 
4.2.4. Results 
The demographic and clinical characteristics of patients included in this phase 
of the research are summarised in Table 4-2. Fifty-six eyes had a single RNFL 
defect and 10 had RNFL defects at two discontiguous locations, resulting in a 
total of 76 RNFL defects. Twenty-six contiguous RNFL defects (34.2%) involved 
1 sector, 40 (52.6%) involved 2 sectors, and 10 (13.2%) involved 3 sectors for a 
total of 136 sectors with and 524 sectors without localised RNFL defects in eyes 
with glaucoma. Sector 9 (inferior-temporal sector) had most RNFL defects (52 
eyes, 78.8%), followed by sector 8 (46 eyes, 69.7%), sector 2 (12 eyes, 18.2%), 
sector 3 (10 eyes, 15.2%), sector 10 (7 eyes, 10.6%) and sector 7 (6 eyes, 
9.1%). There was only one RNFL defect in sector 1 and one in sector 5 and none 
involved sectors 4 or 6 (nasal sectors).  
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Table 4-2. Demographic and clinical characteristics of glaucomatous patients with 
visible localised RNFL defects compared to similarly aged healthy subjects. 
 Healthy 
Eyes = 198 
Subjects = 138 
 
Visible localised 
RNFL defect 
Eyes = 66 
Subjects = 55 
P Value 
Age (years)a 62.5 (55.7 to 69.5) 63.4 (56.1 to 71.6) 0.248c 
Race 
     European 
Ancestry 
     African Ancestry 
 
 
126 
72 
 
27 
39 
0.001d 
Mean Deviation 
(dB) a 
-0.1 (-1.0 to 1.0) -3.3 (-5.9 to -1.4) <0.001c 
Mean RNFL 
thickness (um) 
96.3 ± 10.2 76.0 ± 12.9 <0.001b 
Estimated number 
of RGCs 
968,883 ± 170,230 657,172 ± 163,599 <0.001b 
Global CSFI (%) 1 ± 13 39 ± 15 <0.001b 
CSFI1 (%) 4 ± 19 10 ± 27 0.027b 
CSFI2 (%) 1 ± 21 13 ± 31 0.007b 
CSFI3 (%) -2 ± 22 30 ± 22 <0.001b 
CSFI4 (%) -1 ± 20 19 ± 23 <0.001b 
CSFI5 (%) 2 ± 28 16 ± 30 0.012b 
CSFI6 (%) 3 ± 27 4 ± 34 0.985b 
CSFI7 (%) 2 ± 23 26 ± 28 <0.001b 
CSFI8 (%) -1 ± 18 52 ± 24 <0.001b 
CSFI9 (%) 2 ± 21 52 ± 26 <0.001b 
CSFI10 (%) 3 ± 16 19 ± 42 0.004b 
aMedian (interquartile range), bt-test, cWilcoxon-Rank sum test, dChi-square test 
 
Sectors with visible RNFL defects had significantly worse CSFI, indicating 
greater estimated percentage loss of RGCs, compared to sectors of 
glaucomatous eyes without localised RNFL defects (59 ± 21% versus 15 ± 29% 
respectively, P<0.001) (Table 4-2). The distribution of CSFI in sectors with a 
localised RNFL defect visible defects is shown in Figure 4-4. 
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Figure 4-4. Histogram showing the distribution of CSFI in sectors of glaucomatous 
eyes with visible localised RNFL defects. 
 
Glaucomatous eyes had on average lost 59% of RGCs in sectors with visible 
RNFL defects and 15% in sectors without visible RNFL defects. The sector CSFI 
was worse in glaucomatous compared to healthy eyes in all sectors, except 
sector 6. 
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Figure 4-5. Box plot showing distribution of sector CSFI in healthy eyes compared 
to sectors of glaucomatous eyes with and without visible localised RNFL defects. 
 
Sectors with an RNFL defect had significantly higher CSFI than the 
immediately adjacent sectors (P <0.001), with an average CSFI of 22 ± 24% in 
sectors immediately clockwise and anti-clockwise to RNFL defects.  The sector 
with the maximum estimated RGC loss was in the same sector as a localised 
RNFL defect in 50 eyes (75.8%) and in the same or adjacent sector as a 
localised RNFL defect in 59 eyes (89.4%). Examples of eyes included in this 
phase of the research are shown in Figure 4-6 and Figure 4-7. 
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Table 4-3. Sector CSFI for sectors of glaucomatous eyes with and without visible 
localised RNFL defects (n = 660 sectors). 
 Number of 
RNFL 
defects 
CSFI for sectors 
of glaucomatous 
eyes without 
RNFL defects 
CSFI for sectors of 
glaucomatous eyes 
with RNFL defects 
P-valuea 
Sector 1 2 9 ± 27 43  
Sector 2 12 5 ± 27 50 ± 17 <0.001 
Sector 3 10 25 ± 18 61 ± 14 <0.001 
Sector 4 0 19 ± 23 No eyes with defect in 
sector 4 
 
Sector 5 1 16 ± 30 65  
Sector 6 0 4 ± 34 No eyes with defect in 
sector 6 
 
Sector 7 6 23 ± 27 62 ± 18 <0.001 
Sector 8 46 39 ± 22 58 ± 22 0.002 
Sector 9 52 23 ± 22 60 ± 20 <0.001 
Sector 10 7 12 ± 38 75 ± 32 <0.001 
All sectors 136 15 ± 29 59 ± 21 <0.001 
at test. 
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Figure 4-6. Optic disc photographs, SDOCT and SAP for 3 eyes of patients 
included in the study. Patient one (left column) has an inferior-temporal RNFL 
defect visible on photographs. The CSFI in the sectors corresponding to the 
defect was 57 to 68%. Patient two (central column) has an RNFL defect associated 
with a CSFI of 81 to 85%, indicating an estimated 81 to 85% loss of RGC axons in 
this region. Patient three (right column) has an RNFL defect with a CSFI 21 to 35% 
in corresponding sectors.  
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Figure 4-7. Patient four had a localised RNFL defect visible on photographs 
(arrows) with a CSFI in these sectors of 42 to 48% and a CSFI in other sectors of 0 
to 26%. SDOCT showed localised thinning of the RNFL in the inferior-temporal 
region. Despite high estimated RGC losses, SAP global indices were within 
statistically normal limits.  
 
 
4.2.5. Discussion 
This phase of my research explored the relationship between a common 
structural manifestation of glaucoma, often regarded as an early sign of the 
disease, and estimated losses of RGCs.  The results suggest that if a localised 
RNFL defect is visible on fundoscopy or photographs, it may be associated with 
large localised RGC loss. Eyes with localised RNFL defects had on average 39% 
fewer RGCs than that expected for a healthy similar age subject, this weas 
despite an average MD of only -3.3 dB. Individual sectors with a visible RNFL 
defect had lost an estimated 59% (range of 20 to 100%) of RGCs compared to 
that expected for a healthy eye, which was significantly greater than estimated 
RGC losses in sectors without RNFL defects and in healthy eyes. This estimate 
  110 
was close to the results of histological studies showing loss of 28 to 50% of RNFL 
thickness in regions of a visible RNFL defect (Quigley, & Addicks 1982; Quigley 
1986). The results therefore suggest that rather than being an early sign of 
glaucoma, as traditionally taught, localised RNFL defects visible on photography 
are likely to be associated with large underlying neural losses.  
Most eyes with localised RNFL defects also had repeatable defects on 
perimetry (Figure 4-6), however, 17 of 66 eyes with localised RNFL defects 
(25.8%) had normal SAP. Figure 4-7 shows an eye included in the study with a 
localised RNFL defect visible on photography but without a repeatable SAP 
defect, despite an estimated RGC loss of almost 50% in the sectors 
corresponding to the RNFL defect. Although most sectors with localised RNFL 
defects had large estimated RGC losses, 11 of 136 sectors with an RNFL defect 
(8.1%) had estimated losses of less than 30%, including a single sector with an 
estimated loss of only 20%.  
Localised RNFL defects are defined as areas of abnormality within areas 
of relatively preserved RNFL, therefore detection of a localised defect depends 
on RNFL thickness in neighbouring regions (Quigley, & Sommer 1987). An 
example of this is shown in Figure 4-6, which shows an eye with an RNFL defect 
and relatively low estimated RGC losses (right column). Sectors corresponding to 
the RNFL defect had estimated RGC losses of only 21 to 35%, but the RNFL 
defect may have been visible due relative preservation of the surrounding RNFL, 
with estimated losses of only 0 and 5% in neighbouring sectors. The natural 
history of localised RNFL defects is for them to enlarge to become diffuse defects 
and therefore localised defects are less likely in eyes with more advanced 
  111 
glaucoma (Sommer et al 1977).  They are also more difficult to detect in older 
patients due to poorer visibility of the neighbouring RNFL (Quigley, & Sommer 
1987; Sommer et al 1977; Jonas et al 1989). 
This phase of my research had several major limitations, which mean the 
results should be interpreted with caution. First, although eyes with localised 
RNFL defects were found to have large estimated RGC losses, this was a cross-
sectional study and it is possible that the RNFL defects were visible earlier when 
RGC losses were less. Second, although efforts were taken to minimise rotation 
errors and ensure correct alignment during image acquisition, and fovea-to-disc 
(FoDi) alignment technology was used to automatically track and align circle 
scans, there may have been variation in head or eye position between 
stereophotographs and OCT scans. This may have led to discordance between 
sectorial estimates of RGC count and the sectors with visible RNFL defects. 
Ensuring scans were aligned along the BMO-fovea axis may have produced 
more anatomically sound results; however, the BMO-fovea axis is not visible on 
photographs (Chauhan et al 2013).  A further limitation was the choice of 
structure-function map. Although there is inter-individual variation in the point of 
entry of a particular axon into the ONH (Garway-Heath et al 2000), closer 
examination of the Harwerth map shows some conspicuous areas of 
disagreement between the map and known RGC axon distribution. For example, 
whilst sectors 7 and 9 are adjacent to one another in the Harwerth visual field 
map, they are non-contiguous in the ONH map. This is anatomically implausible 
and does not explain what happens at the point of transition between zones 7 
and 9 and how RGC axons from adjacent zones could come to enter the ONH at 
non-adjacent locations. The Garway-Heath map, which was developed from 
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observation of fundus photographs, would likely have been a better choice of 
map, however, I selected the Harwerth map to be consistent with the method of 
RGC estimation, which was developed using the Harweth map using the same 
sMD estimates. 
The most serious limitation though was that during the course of the work, 
I realised there are major flaws in the assumptions of Harwerth’s formulae (also 
discussed in section 2.4.10, page 76). Foremost, the estimates of RGCs derived 
from SAP and OCT are not independent as the correction for disease severity in 
the OCT-derived estimates defines severity based on SAP MD. The origin for the 
correction factor is also not clear and it has even been suggested by Swanson 
and colleagues that this may have been introduced to allow better correlation 
between SAP and OCT derived estimates and then later explained as a 
correction for disease severity (Swanson, & Horner 2015). A further flaw is that 
OCT-derived estimates of numbers of RGC are consistently lower than estimates 
derived from SAP, which is likely due to Harwerth’s formula assuming the mean 
RGC axon diameter to be larger than that reported in previous studies (Swanson, 
& Horner 2015). Also, the formulae were developed from studies in a limited 
number of animal eyes, in which there was wide variation in histological RGC 
counts and SAP sensitivity at individual locations (Harwerth et al 2010). It is 
therefore possible that the observation that estimates of RGC loss in regions of 
localised RNFL defects were similar to histological studies was a chance finding, 
rather than due to the accuracy of the RGC estimates.  
Although the possibility of being able to estimate RGC loss in glaucoma is 
intriguing, current methods are based on histological data from a very limited 
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number of eyes. Moreover, combining RGC estimates from OCT and SAP may 
not be appropriate given that estimates from SAP will include dysfunctional RGCs 
(some with potential for recovery), whereas estimates from OCT will likely only 
account for RGCs that have shown shrinkage or have undergone apoptosis. Due 
to the limitations of the Harwerth formulae, which are not possible to address 
satisfactorily without further histological studies, the estimates should be 
interpreted with extreme caution.  
My conclusions from this phase of research were that the results suggest 
that localised defects of the RNFL, a common manifestation of glaucomatous 
structural change, may be associated with large underlying RGC losses. 
Therefore, rather than being an early feature of disease, localised RNFL defects 
may be associated with significant neural loss. However, the conclusions 
regarding estimates of RGC loss should be interpreted with extreme caution 
given the limitations of the formulae used. In next phase of my research, I aimed 
to evaluate the relationship between structural changes to the ONH and an 
objective measure of function; the pupillary light response.    
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4.3. The relationship between structural changes and 
pupil response 
4.3.1. Background 
Although glaucoma is typically a bilateral disease, asymmetry is common, 
particularly in the early stages. For example, the Blue Mountains Eye Study, a 
large population study, which examined 3,654 people aged over 49 years in 
Australia, found that of those with glaucomatous visual field loss, 50.5% had 
unilateral defects and 49.5% bilateral defects (Lee et al 2003). Intereye 
differences in IOP (Williams et al 2013; Levine et al 2006), optic disc 
characteristics (Ong et al 1999; Armaly 1969), OCT measurements of cpRNFL 
and macular thickness (Sullivan-Mee et al 2013), and visual field sensitivity 
(Levine et al 2006; Greenfield et al 2007) are all features that raise suspicion of 
glaucoma. In fact, an intereye difference in cup-disc ratio of more than 0.2 has 
long been quoted as a diagnostic criterion for glaucoma (Armaly 1969).  
The detection of intereye asymmetry in optic nerve or macula parameters has 
some possible diagnostic advantages over using isolated measures from one 
eye. For example, OCT normative databases are often used to classify cpRNFL 
thickness as normal, borderline or outside normal limits, however, normative 
databases consist of relatively few subjects, and these subjects have 
homogenous ocular and systemic characteristics (Realini et al 2014). Parameters 
such as cpRNFL thickness exhibit wide overlap between healthy subjects and 
those with early glaucoma and are influenced by patient-specific factors including 
age, gender and ethnicity, increasing the chances of patients with different 
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characteristics to those included in the normative database being misclassified. 
As many of these factors are intrinsic to the individual and will not influence 
intereye asymmetry, using the fellow eye of the same individual for comparison 
may overcome some of these limitations (Sullivan-Mee et al 2013). Eye-specific 
factors such as axial length, which also exhibit wide inter-individual variation, and 
influence structural measurements, are also likely to be similar between eyes and 
so have less influence on intereye asymmetry. A patient’s fellow eye could 
therefore serve as a useful comparative reference for the index eye. Several 
investigators have examined whether assessment of macular or optic nerve 
asymmetry is useful for discriminating between glaucomatous and healthy eyes 
and asymmetry analysis is now incorporated in commercial OCT software for 
glaucoma detection (Figure 4-8).  
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Figure 4-8. Spectralis SDOCT posterior pole asymmetry analysis for a patient with 
glaucoma. Most cells in the left-right eye (OS-OD) asymmetry plot are shaded 
greyscale indicating thinner retinal thickness in the left compared to right eye.  In 
contrast, few of the cells in the left eye are thinner than the right (right-left (OD-OS) 
asymmetry plot). The hemisphere analysis indicates that the inferior retina in both 
eyes is thinner than the superior retina. 
 
A commonly used rapid method of detecting asymmetric damage to the 
afferent visual pathway is the assessment of pupil responses for a relative 
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afferent pupillary defect (RAPD). A RAPD is defined as a difference in average 
pupillary constriction when each eye is stimulated monocularly (Levatin 1959; 
Wilhelm, & Wilhelm 2003; Lankaranian et al 2005).  
The aim of this phase of my research was to evaluate the relationship 
between glaucomatous structural changes and a quantitative measure of pupil 
response. The pupil response serves as a useful objective measure of functional 
impairment; however, asymmetry of pupil response will only be present if there is 
asymmetric impairment to the afferent pathway.  Therefore, I planned to 
determine the magnitude of inter-eye asymmetry in glaucomatous damage 
required for a patient with glaucoma to have a manifest RAPD. I quantified 
‘glaucomatous damage’ in terms of asymmetry in cpRNFL thickness from OCT 
and DLS from SAP. Although aware of the limitations of the Harwerth formula I 
also decided to explore the intereye asymmetry in estimated numbers of RGCs 
using the formulae described in section 2.4.4, page 66. Although a RAPD is not 
specific for glaucoma, previous studies have reported a RAPD in one to two 
thirds of patients with glaucomatous optic neuropathy (Charalel et al 2014; 
Skorkovská et al 2011) leading some to suggest that detection of a RAPD might 
be a useful screening tool (Chang et al 2013b). 
RAPDs are typically detected using the swinging flashlight test, which involves 
illuminating each eye alternately and comparing the velocity and amplitude of the 
pupil response between eyes (Levatin 1959). A RAPD is present when there is 
asymmetry of the light reflex. RAPDs can be quantified by placing neutral density 
filters in front of the normal eye and repeating the swinging flashlight test until the 
pupil responses become symmetric (Thompson et al 1981). However, the 
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swinging flashlight test is somewhat subjective and may be difficult in eyes with 
anisocoria, or dark irides (Wilhelm, & Wilhelm 2003). Automated pupillometry 
allows quantification of individual elements of the pupil response and can detect 
RAPDs with greater sensitivity than the swinging flashlight test (Lankaranian et al 
2005; Jonas et al 1990). For example, Lankaranian and colleagues found a 
RAPD in 39 of 70 patients (56%) with glaucoma using pupillometry compared to 
only 20 (29%) of the same patients with the swinging flashlight test (Lankaranian 
et al 2005). 
Although the magnitude of a RAPD is correlated to the difference in visual 
field loss between eyes (Thompson et al 1982; Johnson et al 1988) and to inter-
eye RNFL differences (Chew et al 2010), there are few studies examining the 
asymmetry of neural loss required for a pupillary abnormality (Kerrison et al 
2001).  Kerrison and colleagues found unilateral loss of 25 to 50% of RGCs was 
required for a RAPD of 0.6 log units in non-human primates, however, this study 
used a macula diode laser to induce RGC loss and assessed pupil reactions 
using the swinging flashlight test, rather than automated pupillometry. 
4.3.2. Purpose 
The aim of this phase of my research was to evaluate the relationship 
between structural changes in glaucoma and pupil responses. Specifically, I 
aimed to examine the asymmetry of cpRNFL, DLS and estimated RGC counts 
required for a clinically detectable RAPD.  
4.3.3. Methods 
For this phase of research 103 participants from DIGS were recruited for 
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pupillometry, in addition to the routine testing previously described (Section 3.2, 
page 84). cpRNFL thickness values were obtained using Cirrus SD-OCT (Section 
3.2.3, page 86).  
Pupillometry 
Pupil responses were tested using a binocular infrared computerised 
pupillometer (RAPDx, Konan Medical USA Inc., Irvine, CA) that measures 
bilateral pupil responses to monocular stimuli (Figure 4-9) (Tatham et al 2014b). 
Stimuli were presented on an LCD screen with a central barrier creating optical 
channels for each eye. The subject viewed the screen at infinity through 50mm 
objective lenses providing an approximate 25-degree field of view in each eye. 
Each half of the screen was selectively activated to stimulate each eye 
separately. Eyes were also illuminated by a pair of infrared emitting diodes, with 
peak emission at 880 nm, mounted at a 35-degree angle.  
Figure 4-9. Binocular infrared computerised pupillometer used to obtain 
quantitative RAPD measurements (image copyright Konan Medical USA Inc., 
Irvine, CA.). 
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The pupil diameter was measured in pixels and converted to millimetres. 
During testing participants were instructed to look at a fixation target displayed on 
the LCD screen. Dark pupil diameter was measured; following which one eye 
was stimulated with a full field white flash stimulus. The stimulus was presented 
for 200ms followed by a period of darkness resulting in a 2.1s duty cycle. The 
stimulus was presented 9 times for each eye for a total test time of 37.8s. The 
right eye was stimulated first, followed by the left, then the right, with further 
stimuli presented to alternate eyes. The stimulus had a luminance of 384 cd/m2 
and there was a nominal background luminance of 0.01 cd/m2. Testing was 
conducted under dark room conditions with an illuminance of <0.5 lux.  
Pupil diameter was continuously monitored during testing to generate a pupil 
diameter waveform. Pupil parameters measured included pre-stimulus pupil 
diameter, minimum pupil diameter following the stimulus, response latency (time 
between stimulus onset and when pupil velocity reached 50% of the peak velocity 
of constriction), time to peak constriction and response amplitude (maximal 
contraction of the pupil as a percentage of the pre-stimulation size). Repetitions 
were averaged (median) before analysis to minimise noise. The RAPDx 
automatically calculates the direction and magnitude of pupil response 
asymmetry as a RAPD score. The RAPD score is calculated as the difference in 
the amplitude of pupil constriction between stimulation of the two eyes using the 
following formula (Sarezky et al 2014): 
RAPD score = 10*Log10 (mean response amplitude in both eyes in response 
to right eye stimulation / mean response amplitude in both eyes in response to 
left eye stimulation) 
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A positive RAPD score therefore indicates a relative abnormality of the left 
afferent system and a negative value an abnormality of the right afferent system.  
As pupil responses may be influenced by medications affecting the autonomic 
nervous system, patients using systemic or topical cholinergic or anticholinergic 
medications were not included in the study. Patients who had previous ocular 
trauma, or intraocular surgery, except for uncomplicated phacoemulsification 
cataract surgery were also excluded. 
 
 
Statistical Analysis 
Descriptive statistics were performed using the methods outlined in section 
3.4, page 89. The relationship between magnitude of RAPD and inter-eye (right 
minus left eye) differences in MD, RNFL thickness, and estimated RGC losses 
(CSFI) were examined using scatter plots and linear regression. To investigate 
the effect of disease severity on asymmetry needed for a RAPD, absolute RAPD 
score was calculated and average MD or RNFL thickness included in the 
regression analysis, with the effect of age also examined as a covariate.  
 
4.3.4. Results 
Seventy-seven patients with glaucoma and 26 healthy controls were recruited 
to this phase of the project (Table 4-4). 52 patients had glaucoma in both eyes 
and 23 had glaucoma in one eye and suspected glaucoma in the other. Table 4-4 
shows patients with glaucoma had significantly higher absolute RAPD scores 
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than controls (P = 0.002) with a mean absolute RAPD score of 0.26 in glaucoma 
compared to 0.10 in controls (Figure 4-10). 
Figure 4-10. Boxplot showing the median, interquartile range, and outside values 
of the absolute RAPD scores in glaucoma and controls.  
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Table 4-4. Characteristics of healthy and glaucomatous subjects. 
 Controls 
N = 26 
Subjects with 
glaucoma in at least 
one eye 
N = 77 
P-
value 
Age (years)* 50.0 ± 15.2 68.9 ± 12.3 <0.001 
Gender 14 (54%) Female 41 (53%) Female 0.958 
Response amplitude 
(%)† 
Worse eye stimulated 
Better eye stimulated 
Inter-eye difference 
 
29.4 (30.4) 27.8 to 
32.6 
29.5 (31.7) 27.6 to 
32.9 
0.6 (0.6) 0.4 to 0.9 
 
26.9 (27.7) 23.5 to 30.8 
27.5 (27.2) 24.2 to 30.3 
1.6 (1.0) 0.5 to 1.9 
 
<0.001 
0.002 
<0.001 
Response latency (ms)† 
Inter-eye difference  
 
4.9 (4.2) 2.2 to 5.3 
 
6.3 (4.6) 1.4 to 9.2 
 
0.652 
Peak constriction (ms)† 
Inter-eye difference 
 
7.6 (5.5) 3.1 to 7.9 
 
11.1 (10.2) 3.6 to 16.6 
 
0.007 
Absolute RAPD score† 0.10 (0.09) 0.05 to 
0.14 
0.26 (0.16) 0.08 to 0.30 0.002 
SAP MD (dB)* 
Worse Eye  
Better Eye  
Inter-eye difference  
 
-0.4 ± 1.1 
0.3 ± 0.9 
0.6 ± 0.5 
 
-5.0 ± 5.7 
-2.1 ± 4.1 
3.0 ± 3.1 
 
<0.001 
0.004 
<0.001 
RNFL thickness (µm)* 
Worse Eye 
Better Eye 
Inter-eye difference 
 
94.5 ± 10.3 
94.5 ± 10.5 
4.0 ± 3.6 
 
74.6 ± 15.4 
80.9 ± 12.8 
10.0 ± 7.9 
 
<0.001 
<0.001 
<0.001 
Estimated RGC count 
(1000’s cells)* 
Worse Eye  
Better Eye  
Inter-eye difference  
 
 
1032 ± 191 
1071 ± 211 
61 ± 49 
 
 
599 ± 211 
724 ± 205 
148 ± 123 
 
 
<0.001 
<0.001 
<0.001 
CSFI (%)* 
Worse Eye 
Better Eye 
Inter-eye difference 
 
3 ± 11 
0 ± 11 
5 ± 4 
 
33 ± 22 
18 ± 21 
17 ± 14 
 
<0.001 
<0.001 
<0.001 
Abbreviations: Response amplitude = maximal contraction of the pupils as a 
percentage of the pre-stimulation pupil size; Response latency = time between stimulus 
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onset and pupil velocity reaching 50% of peak velocity of constriction; Peak constriction 
= time between beginning of stimulus and peak constriction; Relative afferent pupillary 
defect (RAPD) score = 10*Log10 (mean response amplitude of both eyes (in response to 
right eye stimulation) / mean response amplitude of both eyes (in response to left eye 
stimulation)). SAP MD = standard automated perimetry mean deviation, RNFL = retinal 
nerve fibre layer, RGC = retinal ganglion cell, CSFI = combined structure and function 
index. *Mean ± standard deviation, t-test.  †Mean, (median), interquartile range, 
Wilcoxon-rank sum test. 
 
Thirty-two subjects with glaucoma (42%) had an absolute RAPD score ≥ 0.2 
and 19 (25%) had a score ≥ 0.3. In contrast, large absolute RAPD scores were 
not observed in controls, with only 2 having a score ≥ 0.2 and none a score ≥ 0.3. 
There was no significant association between age and absolute RAPD score in 
healthy subjects (R2 = 0.02, P = 0.315) or those with glaucoma (R2 = 0.002, P = 
0.563).  Patients with glaucoma had greater inter-eye asymmetry in MD, RNFL 
thickness and CSFI (Table 4-4). The average number of RGCs estimated in 
those with glaucoma was 598,645 ± 211,062 cells in the worse eye and 723,532 
± 205,344 cells in the better eye compared to 1,031,521 ± 190,906 cells in the 
worse eye of healthy participants and those with glaucoma had an average 
estimated difference of 100,795 cells between eyes compared to 50,456 cells in 
controls. There was reasonable association between the RAPD score and inter-
eye differences in MD (R2 = 0.55, P < 0.001), RNFL thickness (R2 = 0.36, P < 
0.001), estimated RGC counts (R2 = 0.49, P < 0.001) and CSFI (R2 = 0.48, P < 
0.001) (Table 4-5, Figure 4-11).  
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Table 4-5. Regression analysis of RAPD score compared to inter-eye difference (Δ, 
right minus left eye) in MD, RNFL thickness, estimated RGC count and CSFI.  
Inter-eye difference (Δ) Constant Coefficient R2 P value 
MD-Δ (dB) -0.21 8.23 0.55 <0.001 
RNFL thickness-Δ (µm) 1.61 19.99 0.36 <0.001 
RGC estimate-Δ (cells) 21,896 353,272 0.49 <0.001 
CSFI-Δ (%) -1.97 -40.0 0.48 <0.001 
 
As RAPD score is the log of a ratio, and the difference in MD between eyes is 
essentially also a log of a ratio, as it derived from subtracting two logarithmic 
values, I also examined the association between the inter-eye difference in RNFL 
thickness (Figure 4-12) and estimated numbers of RGCs transformed to their 
logarithmic values ( 
Figure 4-13). This showed a similarly strong association between higher (or 
lower) RAPD score and greater difference in log RNFL thickness and log 
estimated number of RGCs, with R2 values of 0.32 (coefficient = 0.26, P<0.001) 
and 0.53 (coefficient = 0.64, P<0.001) respectively.  
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Figure 4-11. Scatter plot showing the relationship between RAPD score and inter-
eye differences in MD (A), RNFL thickness (B), estimated RGC count (C) and CSFI 
(D).  
 
Figure 4-12. Scatter plot showing the relationship between RAPD score and inter-
eye difference in log RNFL thickness. 
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Figure 4-13. Scatter plot showing the relationship between RAPD score and inter-
eye difference in log estimated number of RGCs. 
 
Multivariate analysis showed, subjects with worse average MD tended to 
need a greater inter-eye difference in MD for the same magnitude RAPD score 
as subjects with better average MD (Table 4-6). Table 4-6 shows average MD 
significantly affected the relationship between inter-eye difference in MD and 
magnitude of RAPD. Similarly, subjects with thinner average RNFL thickness 
tended to need greater inter-eye differences in MD for the same magnitude 
RAPD score as subjects with thicker average RNFL (Table 4-7). Subjects with 
thinner average RNFL thickness also needed greater inter-eye differences in 
RNFL thickness for similar magnitude RAPD scores compared to those with 
thicker average RNFL thickness (Table 4-8). Age had no significant effect on the 
relationship between absolute RAPD score and inter-eye differences in structural 
or functional measures.  
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Table 4-6. Multivariate regression analysis of absolute RAPD score and absolute 
inter-eye difference (Δ) in MD including the covariate of average MD (R2 = 0.62, P < 
0.001). 
 Coefficient 95% CI P value 
Absolute RAPD score 
Average MD 
Constant 
6.47 
-0.25 
0.27 
5.41 to 7.53 
-0.31 to -0.19 
-0.07 to 0.61 
<0.001 
<0.001 
0.003 
 
Table 4-7. Multivariate regression analysis of absolute RAPD score and absolute 
inter-eye difference (Δ) in MD including the covariate of average RNFL thickness 
(R2 = 0.51, P < 0.001). 
 Coefficient 95% CI P value 
Absolute RAPD score 
Average RNFL 
Constant 
6.59 
-0.05 
4.99 
5.64 to 7.54 
-0.07 to -0.04 
3.53 to 6.45 
<0.001 
<0.001 
<0.001 
 
Table 4-8. Multivariate regression analysis of absolute RAPD score and absolute 
inter-eye difference (Δ) in RNFL including the covariate of average RNFL (R2 = 
0.19, P < 0.001). 
 Coefficient 95% CI P value 
Absolute RAPD score 
Average RNFL 
Constant 
10.23 
-0.10 
13.75 
6.95 to 13.51 
-0.16 to -0.04 
8.70 to 18.79 
<0.001 
<0.001 
<0.001 
 
I also examined the ability of the RAPD to differentiate healthy and glaucomatous 
subjects. The RAPD score had a sensitivity of only 50% for a specificity of 80% 
(AUC = 0.68, 95% CI 0.58 to 0.78). Expected inter-eye differences for a range of 
RAPD scores are shown in Table 4-9.  
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Table 4-9. Average expected inter-eye differences (Δ) MD, RNFL thickness, 
estimated RGC counts and CSFI for given values of RAPD score.  
Absolute 
RAPD 
score 
 
MD-Δ (dB) if 
average MD 
= -5dB 
MD-Δ (dB) if 
average MD =  
-15dB 
RNFL 
thickness-Δ 
(µm) 
Estimated 
RGC number-
Δ (cells) 
CSFI-
Δ (%) 
0.3 3.5 6.0 6.0 105,982 12 
0.5 4.8 7.3 10.0 176,636 20 
0.7 6.0 8.5 14.0 247,290 28 
0.9 7.3 9.8 18.0 317,945 36 
1.1 8.6 11.1 22.0 388,599 44 
 
Figure 4-14 and Figure 4-15 show examples of two patients included in this 
phase of the study.  
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Figure 4-14. 56-year-old patient with early glaucoma in the left eye. The blue 
pupillometer trace shows the average of right and left pupil diameters on right eye 
stimulation and the red trace the average pupil diameters on left eye stimulation. 
MD was 0.73 dB and -0.39 dB in right and left eyes with estimated RGC counts of 
1,005,524 and 864,756 respectively. The average response amplitude (A) on right 
eye stimulation was 0.30 compared to 0.27 on left eye stimulation, giving a RAPD 
score of 10*Log10(0.30/0.27) = 0.46 and indicating a relative abnormality of the left 
afferent pathway.  
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Figure 4-15. 70-year-old patient with advanced glaucoma in both eyes. MDs were -
23.56 dB and -15.79 dB in right and left eyes with estimated RGC counts of 111,000 
and 237,996 respectively. The RAPD score was -0.10, indicating a small relative 
abnormality of the right afferent pathway. 
 
 
4.3.5. Discussion 
This component of my research examined the relationship between 
glaucomatous structural and functional changes and magnitude and direction of 
RAPD and found a strong relationship between these measures (Figure 4-11). 
Individuals with larger RAPDs had greater inter-eye differences in RNFL 
thickness, MD and estimated RGC losses. Table 4-5 shows that each 0.1 
increase in RAPD score was likely to correspond to an increase in RNFL 
asymmetry of 2 µm. Therefore, a RAPD score of 0.5 (or -0.5) is likely to represent 
an inter-eye difference in RNFL thickness of 10 µm and a RAPD score of 1.1, an 
inter-eye difference in RNFL thickness of 22 µm. A RAPD score of 0.5 
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corresponded to an inter-eye estimated RGC difference of approximately 177,000 
cells compared to an inter-eye difference of 389,000 cells for a RAPD score of 
1.1.  
Although pupil response asymmetry was quantified using a pupillometer 
rather than by using neutral density filters, the results suggest that a RAPD score 
of 0.6 would correspond to an inter-eye CSFI difference of approximately 24%, 
which is like the results of a previous histological study showing unilateral loss of 
at least 25% of RGCs was required for a 0.6 log unit RAPD measured using 
neutral density filters (Kerrison et al 2001). The estimates were also similar to a 
previous study in human subjects with a variety of neurological diseases in which 
RGC numbers were estimated by overlying templates of known RGC density on 
visual fields (Lagrèze, & Kardon 1998). A 1.0 log unit RAPD was associated with 
asymmetric RGC losses of 30-40%, compared to an estimated loss of 40% of 
RGCs for a similar magnitude RAPD in our study. An important difference is that 
Lagrèze and colleagues used visual field sensitivity alone to estimate RGC 
counts, whereas in my analysis RGC numbers estimated from a combination of 
SAP and OCT information.   
Previous studies have examined inter-eye differences in RNFL thickness and 
MD associated with asymmetric pupil responses to a flashlight (Chew et al 2010; 
Tatsumi et al 2007) or pupillometer (Chang et al 2013a). Using the swinging 
flashlight test, an inter-eye difference in RNFL thickness of 17 to 27%, or an inter-
eye difference in SAP MD of 9.5 dB to 12 dB was needed for a RAPD of at least 
0.3 to 0.6 log units (Chew et al 2010; Tatsumi et al 2007).  Automated 
pupillometry is likely to be able to detect smaller RAPDs and the results of my 
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analysis show a RAPD score of 0.3 was associated with an inter-eye difference in 
MD of only 6.0 dB if the average MD in both eyes was -15dB and only 3.5 dB if 
the average MD was -5 dB. Using a similar pupillometer to that used in this phase 
of my research, Chang and colleagues found a RAPD score of 0.3 to be 
associated with an inter-eye difference in MD of 2.6 dB and RNFL thickness of 
3.2 µm, which was similar to my results (Chang et al 2013a). However, Chang 
and colleagues did not examine the influence of disease severity on this 
relationship. Results from my work at UCSD showed that patients with worse 
average MD required a greater inter-eye difference in MD for a similar size RAPD 
as patients with earlier disease. For example, when average MD is -5 dB, an 
inter-eye difference in MD of approximately 4.8 dB is likely to be required for an 
absolute RAPD score of 0.5, compared to an inter-eye difference in MD of 7.3 dB 
for a similar magnitude RAPD in patients with an average MD of -15dB. 
Average MD is likely to influence the relationship between inter-eye difference 
in MD and magnitude of RAPD as the inter-eye difference in numbers of 
functioning RGCs is likely to decrease with worsening disease severity in patients 
that may have initially had symmetrical disease. Further, SAP thresholds are 
acquired and presented using a logarithmic scale. As discussed in section 2.3, 
page 51, due to the logarithmic scale of SAP, in early disease one would expect 
large RGC losses to occur for a relatively small change in MD. Therefore, in early 
disease a small difference in MD between eyes may represent a relatively large 
difference in numbers of RGCs between eyes. Later in disease a small difference 
in MD between eyes may represent a relatively small inter-eye difference in 
functioning RGCs. It should however, also be emphasised that the RAPD score is 
also a logarithmic scale, which is useful for measuring small degrees of pupil 
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response asymmetry, but may lead to loss of information. To evaluate this, I also 
examined the relationship between inter-eye differences in structural and 
functional measures and pupil response asymmetry measured as the difference 
in response amplitude between eyes. Similar results were obtained compared to 
using the RAPD score.   
Of course, it is important to emphasise that as glaucoma is usually a bilateral 
disease, assessment of RAPD is unlikely to be a useful tool for screening, as has 
been suggested by some (Chang et al 2013b). Furthermore, the presence of a 
clinically detectable RAPD in a patient with suspected glaucomatous optic 
neuropathy and good vision should in fact alert the clinician to the possible 
presence of a non-glaucomatous optic neuropathy. Few patients included in this 
phase of the research had grossly asymmetric disease, with only 13 subjects with 
glaucoma (17%) having an inter-eye mean deviation difference ≥5 dB. Using the 
data from this phase of my research, the RAPD score had a sensitivity of only 
50% for a specificity of 80% for distinguishing those with glaucoma from healthy 
subjects (AUC = 0.68, 95% CI 0.58 to 0.78). It is also important to recognise that 
healthy subjects often have small RAPDs by pupillometry that are not seen on 
clinical examination, with one study reporting RAPDs between 0.08 and 0.22 log 
units in 42% of healthy subjects (Wilhelm et al 2007). 
An aim of this phase of my research was to determine the inter-eye 
asymmetry in structural parameters needed for a clinically detectable RAPD in 
glaucoma. Although I did not use the swinging flashlight test in this study, the 
swinging flashlight test can detect a RAPD of approximately 0.3 log units, which 
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equated to an inter-eye difference in RNFL thickness of 6 µm in the present study 
(or a difference in estimated RGC losses of 12%) (Wilhelm et al 2007). 
This phase of my research had several limitations, in addition to the limitations 
of the method of estimating RGC counts previously discussed (section 2.4.10, 
page 76).  First the healthy subjects were significantly younger than those with 
glaucoma. Although RGC loss occurs with normal ageing, this is likely to be 
symmetrical and not affect the symmetry of pupil responses. Further, age had no 
effect on the relationship between inter-eye measures of glaucoma severity and 
magnitude of RAPD score. Also, specific RGC subtypes (e.g., the intrinsically 
photosensitive melanopsin containing RGCs or ipRGCs (Kawasaki, & Kardon 
2007; Kankipati et al 2011)) are involved in the pupillary light response and loss 
of these cells may disproportionately affect the pupil response. Although the 
pupillometer did not specifically target individual RGC subtypes this may not have 
been important as previous investigations have shown ipRGCs have a uniform 
distribution and therefore loss is likely to be proportional to total RGC loss 
(Kawasaki, & Kardon 2007; Kankipati et al 2011). The symmetry of pupil 
responses may also be affected by differences in decussation of fibres at the 
optic chiasm and midbrain, which was not evaluated.  In addition, some subjects 
with asymmetric glaucoma whom one might expect to have a large RAPD did 
not. Figure 4-15 shows a patient with bilateral advanced glaucoma and a large 8 
dB difference in MD between eyes but a RAPD score of only 0.1. This patient had 
an estimated RGC difference of 126,996 cells between eyes, however the model 
suggested a RAPD of 0.1 would be associated with an inter-eye difference in 
estimated RGC count of only 35,327 cells. The large difference in estimates for 
this patient is because the model only explains 50% of the variability in RAPD 
  136 
score. Furthermore, I only evaluated a full-field stimulus and it is possible that, 
depending on the location of visual field loss, by stimulating smaller sections of 
the retina, a larger proportion of patients with glaucoma may be found to have a 
RAPD. However, this strategy may also increase the number of false positives as 
small RAPDs detectable by pupillometry are not that infrequent in healthy 
subjects.  
Despite these limitations, this component of my research has provided several 
new insights into the relationship between glaucomatous structural losses and 
functional change. Overall there was good correlation between magnitude of a 
RAPD and the inter-eye difference in RNFL thickness, MD and estimated number 
of RGCs. A large RAPD is therefore likely to indicate significant asymmetry of 
each of these parameters.  It is though important to emphasise that patients with 
severe bilateral disease may have symmetric pupil reactions. The final phase of 
this body of work was to examine the relationship between glaucomatous 
structural changes and a more complex task related to visual function, and of 
direct relevance to quality of life: the ability to drive. 
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4.4.  The relationship between structural changes and 
ability to perform vision-related tasks 
4.4.1. Background 
Although structural measurements, such as RNFL thickness, are widely used 
for diagnosing glaucoma and measuring progression, the real clinical relevance 
of these measurements remains unclear (McKean-Cowdin et al 2007; Medeiros 
et al 2012). For example, it is not known at which point structural changes 
become associated with decrease in the ability to perform vision-related tasks 
important for daily living. It is important to understand this relationship as 
structural measurements are increasingly used to inform management decisions 
regarding follow up intervals and treatment, whereas the impact of disease on 
daily living is of paramount importance to patients. Until recently there has been 
insufficient research into how glaucoma affects quality of life and activities of daily 
living, and most previous studies have relied solely on questionnaires (Glen et al 
2011). Responses to questionnaires can be affected by patient’s personality and 
attitudes, which vary, limiting the usefulness of cross-sectional data.  
Although SAP is used to assess visual function in glaucoma, when it comes to 
assessing the impact of visual impairment on real-world tasks, SAP has 
limitations (Richman et al 2010). SAP has relatively few test points in the central 
field and does not evaluate important components of vision such as motion 
perception. In addition, SAP is performed under artificial conditions with minimal 
visual distractions whereas daily activities often require the ability to divide 
attention or multi-task (Broman et al 2004; Owsley, & McGwin 2010). Divided 
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attention is defined as the ability to process and/or respond to information from 
one task while simultaneously conducting another (Ball, & Owsley 1993). 
Therefore, rather than investigate the relationship between structural 
measurements and SAP, as has been done by previous investigators, the aim of 
the next phase of my research was to investigate the relationship between 
structural measurements and ability to perform a task of direct relevance to daily 
living, in this case driving. A secondary aim was to determine whether structural 
information might provide additional value compared to SAP alone in predicting 
the ability to perform vision-related tasks.  
Previous studies have shown that ability to drive is intimately related to 
health-related quality of life, with driving cessation associated with increased risk 
of depression, social isolation and entry into residential care (Marottoli et al 1997; 
Fonda et al 2001; Ragland et al 2005). On the other hand, driving is a highly 
visual task, and continued driving in the presence of significant visual impairment 
is likely to be associated with increased risk of collisions, with potentially serious 
implications for the individual and society (Wood et al 2016). Previous studies 
have shown that drivers with glaucoma are at increased risk of collisions 
(Haymes et al 2007; Tanabe et al 2011; McGwin et al 2005).  Haymes and 
colleagues reported drivers with glaucoma to be over 6 times more likely to have 
been involved in a collision compared to similarly aged controls (Haymes et al 
2007).  However, perhaps as driving is a complex task, and due to the limitations 
of SAP discussed above, previous studies have shown only a weak association 
between motor vehicle collisions and SAP (Richman et al 2010; Owsley, & 
McGwin 2010). 
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The ability to divide attention is intrinsically related to driving, as a driver is 
required to continuously monitor information from the roadway while 
simultaneously maintaining awareness of potential hazards surrounding the 
vehicle (Owsley, & McGwin 2010; Owsley et al 1998). For this reason, failures of 
divided attention are a leading cause of collisions, accounting for as many as 22 
to 50% of incidences (Brouwer et al 1991; Klauer et al 2006; Rubin et al 2007). 
Problems with divided attention have also been associated with difficulties 
performing other activities of daily living such as walking (Broman et al 2004). 
The Visual Performance Laboratory at UCSD, led by Professor Felipe Medeiros, 
has recently developed a driving simulator that provides a means to assess 
ability to divide attention under simulated driving conditions. The aim of the Visual 
Performance Laboratory is to explore the effect of eye disease on visual function 
and ability to perform activities of daily living. I was fortunate to be able to use this 
apparatus for this component of my research secondment at UCSD.  
4.4.2. Purpose 
The purpose of this phase of my research was to improve understanding of 
the ‘structure-function relationship’ by determining the relationship between an 
objective measure of glaucomatous structural damage and ability to perform a 
vision-related task of direct relevance to an activity of daily living.  
4.4.3. Methods 
Drivers with glaucoma attending HGC were recruited for involvement in this 
cross-sectional observational study. Written informed consent was obtained from 
all participants. All subjects underwent a comprehensive ophthalmologic 
examination, SDOCT (Spectralis, Heidelberg Engineering, Dossenheim, 
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Germany) and SAP in accordance with the methods outlined in Section 3.2, page 
84. Patients were categorised has having glaucoma using the criteria defined in 
Section 3.3, page 88 Categorisation was based on diagnosis in the worse eye.  
Driving Simulator  
The driving simulator consisted of a driving seat, a steering wheel, brake and 
accelerator pedals, and a flat screen monitor as shown in Figure 4-16. The 
position of the seat, wheel and pedals could be adjusted but the distance 
between the subject’s head and the centre of the screen was set at 43-inches. 
The screen width was 35-inches resulting in a driving scene with a 45-degree 
horizontal field of view.  
Erwin Boer, Professor in the Department of Mechanical Engineering at Delft 
University of Technology, Netherlands, and Visiting Professor at the Institute for 
Transport Studies, University of Leeds, UK, developed the software for the 
driving simulator. The aim was that the simulator should assess a wide range of 
patient response parameters to simulated driving scenarios and, given the 
importance of failures of divided attention in motor vehicle collisions, a divided 
attention task was included in the programme. The simulator used two basic 
driving tasks involving car following and curve negotiation. For the car following 
task the driver was instructed to follow a lead vehicle that varies its speed at a 
short distance, controlling the accelerator and brake (Figure 4-17).  
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Figure 4-16. Photograph of the driving simulator apparatus. 
 
Figure 4-17. Screenshot of the driving simulator car following task. 
 
 
For the curve negotiation task, the driver was required to stay in the centre 
lane of a three lane, winding road Figure 4-18). The velocity of the vehicle was 
constant such that the driver only had to operate the steering wheel. The vehicle 
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speed was set at 15 m/s (54 km/h) for the first half of the test, increasing to 25 
m/s (90 km/h) for the second half of the test (Marsden et al 2001). 
Figure 4-18. Screenshot of the driving simulator curve negotiation task. 
 
While performing the central tasks (car following or curve negotiation), 
simultaneous peripheral (divided attention) stimuli were periodically shown at 
about 20-degrees of visual angle in the upper right and upper left of the driving 
simulator screen and at three different contrasts (low, medium and high with 
Michelson contrasts of 0.04, 0.14 and 0.27) (Figure 4-17 and Figure 4-18). The 
background was a constant cloudy sky.  The driver was required to press a 
button on the steering wheel to register that the stimulus had been perceived. 
There was an average of 5 stimuli presented at each contrast for each central 
driving task (a total of about 15 per 3 minutes or about one every 12 seconds) 
and stimuli stayed on the screen for a maximum of 3 and 6 seconds (uniform 
distribution) or until the driver responded. The next stimuli appeared between 3 
and 6 seconds (again uniform distribution) after the driver responded or when the 
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maximum display time had elapsed. To minimize the effect of unreliable tests and 
learning effect, all subjects underwent driving simulator training prior to test 
commencement. Training consisted of 2 minutes of practice acceleration and 
deceleration, followed by 1 minute of each of the car following and curve 
negotiation tasks. 
Driving Simulator Outcome Variables 
The main outcome variable of interest was reaction time to the divided 
attention peripheral stimulus, which was defined as the time interval between 
appearance of the peripheral stimulus and the subject pressing the button, with a 
longer reaction time indicating worse performance. The mean reaction time for 
each central task and contrast was calculated to give a total of 6 sets of reaction 
times for each subject (high, medium and low contrasts for car following and 
curve negotiation tasks). We also calculated the false positive percentage, 
defined as the number of button presses occurring when no stimulus had been 
presented divided by the total number of stimuli presented. Reaction time was 
chosen as the outcome variable as difficulties with divided attention tasks seem 
to be related, at least in part, to a slowing of visual processing speed. Visual 
processing speed, which is the time needed to make a correct judgment about a 
visual stimulus, is commonly studied in behavioural research by measuring 
reaction times.  
As a subject might neglect the central driving task to concentrate on the 
peripheral stimuli, and thereby achieve falsely fast reaction times, it was 
important to also measure central task performance and ensure the patient was 
truly dividing attention. Central task performance was assessed using curve 
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coherence and speed coherence. Curve coherence, which is a measure of 
correlation between road curvature and the vehicle path curvature, was 
calculated using the following equation, where n is the number of samples of the 
two signals and SD is the standard deviation of the signals.  
 
A coherence of 1 indicated exact agreement between the road and vehicle 
path curvature or good performance on the central driving task. Speed coherence 
is like curve coherence but measures how well the driver can match the speed 
changes of the lead vehicle. Speed coherence was calculated using the following 
equation, where CCF is the cross-correlation function, n is the number of samples 
of the two signals and SD is the standard deviation of the signals (Brookhuis et al 
1994). 
 
A potential problem of using reaction times as a measure of visual processing 
is that registering the reaction time includes a motor response, likely to be 
influenced by age, among other factors (Hultsch et al 2002). As one would expect 
the motor response for a subject to be constant regardless of stimulus contrast, 
we attempted to minimise the contribution of the motor response by calculating 
the difference in reaction times to the low and high contrast stimuli.  Reaction 
times and driving ability are also dependent on cognitive ability so all subjects 
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completed a Montreal Cognitive Assessment, a 30-point, ten-minute cognitive 
screening tool (Figure 4-19) (Nasreddine et al 2005). As driving experience might 
also affect performance on the driving simulator, driving habits questionnaires 
were completed to assess the average number of miles driven over the past 3 
years. 
Statistical Analysis 
Descriptive statistics were performed using the methods outlined in section 
3.4, page 89. The relationship between the reaction times and RNFL thickness in 
each subject’s better and worse eyes were examined using scatter plots and 
locally weighted scatterplot smoothing (LOWESS) curves. As reaction times were 
positively skewed, base-10 logarithms were calculated for further analysis. Other 
variables examined as potentially confounding factors included age, Montreal 
Cognitive Assessment score, SAP MD and distance driven per week. The 
relationship between reaction times and stimulus contrast was also examined 
using a mixed effects linear regression model. 
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Figure 4-19. Montreal Cognitive Assessment.  
 
 
4.4.4. Results 
The study included 82 subjects with glaucoma and 76 similarly aged controls, 
including 30 healthy subjects and 46 with suspect glaucoma and OHT but normal 
visual fields. There were no significant differences in age, gender, ancestry, 
cognitive ability or average distance driven per week between controls and those 
with glaucoma (Table 4-10). 
  147 
Table 4-10. Demographic and clinical characteristics (mean (median, interquartile 
range)) of patients with glaucoma compared to controls. 
 Controls (76 subjects) 
Glaucoma 
(82 subjects) P-value 
Age (years) 61.2 ± 9.2 64.2 ± 12.2 0.093a 
Sex, female (%) 34 (44.7%) 35 (42.7%) 0.873c 
Ethnicity 
Caucasian 
African-American 
53 (69.7%) 
17 (22.4%) 
51 (62.2%) 
19 (23.2%) 0.783
c 
MD worse eye (dB) -0.2 (0.1, -0.8 to 0.7) 
-6.4 
(-3.9, -8.7 to -1.6) <0.001
b 
MD better eye (dB) 0.5 (0.7, -0.2 to 1.3) 
-2.3 
(-1.2, -3.4 to 0.1) <0.001
b 
RNFL thickness worse eye (μm) 90 (91, 83 to 98) 
71 
(70, 60 to 80) <0.001
b 
RNFL thickness better eye (μm) 94 (94, 87 to 100) 
79 
(78, 67 to 90) <0.001
b 
Pseudophakic in at least one eye 
(number of patients (%)) 10 (13.2%) 17 (20.7%) 0.290
c 
Montreal Cognitive Assessment score 28 (29, 27 to 30) 
28 
(28, 26 to 30) 0.350
b 
Average distance driven per week (miles) 143 ± 18 125 ± 18 0.065a 
Curve Negotiation Metrics 
Curve coherence  0.93 (0.95, 0.90 to 0.97) 
0.91 
(0.95, 0.89 to 0.98) 0.978
b 
False positives (%) 9.2 (3.1, 2.0 to 6.7) 
9.2 
(2.4, 0 to 9.1) 0.599
b 
Divided Attention Reaction Time –  
Low contrast (s) 
0.64 
(0.59, 0.52 to 0.70) 
1.05 
(0.70, 0.61 to 1.02) <0.001
b 
Divided Attention Reaction Time – 
Medium contrast (s) 
0.55 
(0.52, 0.48 to 0.63) 
0.59 
(0.57, 0.49 to 0.64) 0.142
b 
Divided Attention Reaction Time –  
High contrast (s) 
0.55 
(0.53, 0.46 to 0.60) 
0.58 
(0.55, 0.49 to 0.66) 0.167
b 
Low contrast minus high contrast 
reaction time (s) 
0.09 
(0.07, 0.03 to 0.10) 
0.47 
(0.13, 0.07 to 0.40) <0.001
b 
Car Following Metrics 
Speed coherence  0.93 (0.95, 0.90 to 0.97) 
0.91 
(0.95, 0.89 to 0.98) 0.978
b 
False positives (%) 6.5 (2.7, 0 to 5.5) 
6.3 
(2.7, 0 to 5.6) 1.000
b 
Divided Attention Reaction Time –  
Low contrast (s) 
0.77 
(0.62, 0.54 to 0.85) 
1.19 
(0.69, 0.58 to 1.22) 0.025
b 
Divided Attention Reaction Time – 
Medium contrast (s) 
0.62 
(0.54, 0.50 to 0.64) 
0.62 
(0.56, 0.50 to 0.66) 0.956
b 
Divided Attention Reaction Time –  
High contrast (s) 
0.57 
(0.54, 0.50 to 0.61) 
0.65 
(0.55, 0.50 to 0.64) 0.412
b 
Low contrast minus high contrast 
reaction time (s) 
0.20 
(0.08, 0.03 to 0.30) 
0.48 
(0.11, 0.03 to 0.60) 0.199
b 
at-test, bWilcoxon rank sum test. cFishers exact test.  
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Subjects with glaucoma had slower reaction times to the low contrast divided 
attention stimuli compared to controls ( 
Figure 4-20 and Table 4-10) with median reaction times of 1.05 and 1.19s for 
the curve negotiation and car following tasks in those with glaucoma compared to 
0.64 and 0.77s respectively in controls (P < 0.001 for both comparisons). There 
was no significant difference between groups for the less demanding medium 
and high contrast stimuli, and false positive rates were similar between groups 
(Table 4-10).  
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Figure 4-20. Box-plots showing reaction times to the curve negotiation and car 
following driving simulator divided attention tasks for drivers with glaucoma and 
controls.  
 
There was a significant non-linear relationship between RNFL thickness in the 
better and worse eyes and log10 reaction times to the driving simulator divided 
attention tasks at low contrast (ρ = -0.480; P <0.001 and ρ = -0.481; P <0.001 for 
the better and worse eyes respectively for the curve negotiation task and ρ = -
0.280; P <0.001 and ρ = -0.281; P <0.001 for better and worse eyes using the car 
following task (Figure 4-21). There was a similar exponential relationship 
between RNFL thinning and reaction times before the logarithmic transform. 
  150 
Although there was a similar relationship between RNFL thickness and reaction 
times to the medium and high contrast stimuli, the strongest relationship was with 
the more demanding low contrast stimulus, which was used for all further 
analyses. There was also a significant relationship between SAP MD in the better 
and worse eyes and log10 reaction times to the driving simulator divided attention 
tasks at low contrast (ρ = -0.480; P <0.001 and ρ = 0.509; P<0.001 for better and 
worse eyes respectively for the curve negotiation task and ρ = -0.315; P <0.001 
and ρ = -0.324; P <0.001 for the better and worse eyes for the car following task) 
(Figure 4-22 and Figure 4-23). There was a significant increase in divided 
attention reaction times with increasing age (ρ = 0.434; P<0.001 for the curve 
negotiation task and ρ =0.324; P<0.001 for the car following task) (Figure 4-24).  
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Figure 4-21. Scatter and LOWESS plots showing the relationship between RNFL 
thickness in the better eye and reaction times to low contrast divided attention 
stimuli during the curve negotiation and car following simulated driving tasks. 
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Figure 4-22. Scatter and LOWESS plots showing the relationship between MD in 
the better eye and reaction times to low contrast divided attention stimuli during 
the curve negotiation and car following simulated driving tasks. 
 
 
  153 
Figure 4-23. Scatter and LOWESS plots showing the relationship between MD in 
the worse eye and reaction times to low contrast divided attention stimuli during 
the curve negotiation and car following simulated driving tasks. 
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Figure 4-24. Scatter and LOWESS plots showing the relationship between age and 
reaction times to low contrast divided attention stimuli during the curve 
negotiation and car following simulated driving tasks. 
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 A multivariable model was developed to characterise the relationship 
between RNFL thickness and reaction times to the driving simulator divided 
attention tasks. The model included a quadratic term to account for nonlinearity. 
RNFL thickness in the better eye remained significantly predictive of reaction 
times, even after accounting for age, MD in the better eye, performance on the 
central driving task, and the cognitive assessment score (P = 0.001 (joint Wald 
test) for curve negotiation task and P = 0.019 for car following task) (Table 4-11). 
Worse MD in the better eye and worse performance on the central driving tasks 
were also associated with slower reaction times to the divided attention tasks, as 
was older age for the curve negotiation task (Table 4-11).  The modelled 
relationship between RNFL thickness in the better eye and reaction times to the 
divided attention tasks are shown in Figure 4-25. 
 
  156 
Table 4-11. Results of multivariable regression analyses examining the 
relationship between RNFL thickness in the better eye and driving simulator 
divided attention reaction times at low contrast (in logarithmic units). 
Curve Negotiation Task 
Divided attention reaction time at low contrast, adjusted R2 = 0.469 
 Coefficient 95% CI P-Value 
RNFL thickness in better 
eye (per 10μm) -0.24 -0.40 to -0.10 0.001 
RNFL thickness in better 
eye squared (per 100μm2) 0.01 0.00 to 0.02 0.004 
Age (per 10 years) 0.03 0.02 to 0.05 0.035 
MD in better eye (dB) -0.02 -0.03 to -0.01 <0.001 
Curve coherence -0.63 -1.10 to -0.15 0.010 
Montreal Cognitive 
Assessment score -0.01 -0.02 to 0.01 0.337 
Constant 1.59 0.74 to 2.44 <0.001 
 
Car Following Task 
Divided attention reaction time at low contrast, adjusted R2 = 0.316 
 Coefficient 95% CI P-Value 
RNFL thickness in better 
eye (per 10μm) -0.22 -0.41 to -0.04 0.019 
RNFL thickness in better 
eye squared (per 100μm2) 0.01 0.00 to 0.02 0.004 
Age (per 10 years) 0.03 0.00 to 0.06 0.057 
MD in better eye (dB) -0.02 -0.03 to -0.01 0.001 
Speed coherence -0.34 -0.65 to -0.04 0.029 
Montreal Cognitive 
Assessment score 0.00 -0.01 to 0.02 0.712 
Constant 0.99 -0.05 to 2.02 0.062 
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Figure 4-25. Predicted reaction times to the low contrast divided attention stimuli 
for the curve negotiation and car following simulated driving tasks. 
 
The difference between reaction times to the low and high contrast stimuli, 
calculated to minimise the contribution of the motor response to reaction times, 
was also related to RNFL thickness in the better eye for car following (spearman 
rank correlation ρ = -0.458; P <0.001) and curve negotiation tasks (spearman 
rank correlation ρ = -0.262; P <0.001), even accounting for confounding factors 
(Table 4-12).  
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Table 4-12. Results of multivariable regression analyses examining the 
relationship between RNFL thickness in the better eye and the difference in 
reaction times to the driving simulator divided attention tasks at high and low 
contrast.  
Curve Negotiation Task 
Driving simulator divided attention reaction time at low contrast minus reaction 
time at high contrast, adjusted R2 = 0.327. 
 Coefficient 95% CI P-Value 
RNFL thickness in better 
eye (per 10μm) -0.78 -1.28 to -0.27 0.003 
RNFL thickness in better 
eye squared (per 100μm2) 0.04 0.01 to 0.07 0.010 
Age (per 10 years) 0.06 -0.03 to 0.15 0.207 
MD in best eye (dB) -0.06 -0.09 to -0.02 0.001 
Curve coherence -1.10 -2.91 to 0.72 0.235 
Montreal Cognitive 
Assessment score -0.01 -0.05 to 0.03 0.759 
Constant 4.78 1.54 to 8.03 0.004 
 
Car Following Task 
Driving simulator divided attention reaction time at low contrast minus reaction 
time at high contrast, adjusted R2 = 0.256. 
 Coefficient 95% CI P-Value 
RNFL thickness in better 
eye (per 10μm) -0.85 -1.51 to -0.18 0.014 
RNFL thickness in better 
eye squared (per 100μm2) 0.04 0.01 to 0.08 0.026 
Age (per 10 years) 0.05 -0.01 to 0.16 0.421 
MD in best eye (dB) -0.07 -0.12 to -0.03 0.002 
Speed coherence -0.41 -1.48 to 0.65 0.444 
Montreal Cognitive 
Assessment score 0.01 -0.04 to 0.06 0.738 
Constant 4.09 0.39 to 7.79 0.030 
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A 0.1 decrease in Michelson contrast was associated with 0.077 (95% CI 
0.059 to 0.096) and 0.075 (95% CI 0.053 to 0.098) increases in curve negotiation 
and car following reaction times (in logarithmic units) in those with glaucoma, 
compared to increases of only 0.026 (95% CI 0.016 to 0.035) and 0.046 (95% CI 
0.032 to 0.059) in controls. 
 
4.4.5. Discussion 
This phase of my research had several important findings. First, compared 
to similarly aged controls, drivers with glaucoma were found to have impaired 
ability to divide attention during the simulated driving tasks using low contrast 
stimuli. Impaired ability to divide attention has potentially serious consequences, 
as it is likely to affect the ability of a subject to perceive a dangerous situation in a 
timely manner.  
The second important finding was that ability to divide attention was 
related to measures of glaucoma severity, with longer reaction times observed in 
patients with more severe disease. Therefore, whereas drivers with early 
glaucoma had reaction times to divided attention tasks like controls, those with 
advanced disease tended to have slower reaction times. There was a significant 
relationship between RNFL thinning and longer reaction times to the divided 
attention tasks (Figure 4-21), and a significant relationship between worse SAP 
MD and longer reaction times; however, RNFL thickness provided additional 
information (Table 4-11). This suggests that structural measurements might 
provide additional information compared to SAP in evaluating the likely impact of 
glaucoma on ability to perform tasks of daily living and therefore quality of life.  
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Although ophthalmologists tend to rely on SAP to assess functional losses 
in glaucoma, several studies have shown only a weak relationship between SAP 
and quality of life, or SAP and ability to perform daily activities (van Gestel et al 
2010; Richman et al 2010; McKean-Cowdin et al 2007; Owsley, & McGwin 2010). 
It is possible that SAP may not fully capture changes in vision that are relevant to 
ability to perform some everyday tasks like driving such as motion perception or 
visual multi-tasking.  Recent work has also indicated that significant neural losses 
may occur in the macular area of patients with glaucoma, which are likely to be 
relevant to daily tasks and may not be fully captured by SAP (Hood et al 2013). 
As contrast has previously been shown to adversely affect driving 
performance, (Richman et al 2010) we decided to evaluate ability to divide 
attention using low, medium and high contrast stimuli. This methodology also 
allowed us to calculate the difference in reaction times to high and low contrast 
stimuli (‘motor response corrected’ reaction time), to minimise the contribution of 
the motor response to reaction times. Although divided attention reaction times 
increased with decreasing contrast for drivers with glaucoma and controls, drivers 
with glaucoma were worse affected. For example, drivers with glaucoma had a 3-
fold greater increase in reaction times (in logarithmic units) compared to controls 
with decreasing contrast during the curve negotiation task, a finding consistent 
with previous studies showing patients with glaucoma to be more affected by low 
contrast than controls (Burton et al 2012; Richman et al 2010). For example, 
Burton and colleagues recently reported that patients with glaucoma have more 
difficulty reading at low contrast compared to healthy individuals (Burton et al 
2012).  
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Thinner RNFL in the better eye was also associated with larger differences 
in reaction time to low and high contrast stimuli suggesting the relationship 
between RNFL thickness and reaction time during simulated driving was not due 
to differences in motor response (Table 4-12). Although the difference in reaction 
time between low and high contrast stimuli was not significantly different between 
patients with glaucoma and controls (Table 4-10), this is likely due to the 
relatively large number of patients with early and moderate glaucoma, as there 
was a significant association between MD and RNFL thickness and the ‘motor-
response corrected reaction time’. Average distance driven per week was 
recorded but was not significantly associated with reaction times to the divided 
attention tasks. There was also no evidence of difference in speed-accuracy 
trade-offs between glaucomatous and healthy individuals as indicated by similar 
rates of false-positive responses.  
Although this phase of my research project fulfilled the objective to 
evaluate the relationship between a structural measure of glaucomatous neural 
loss and ability to perform a task relevant to daily living, the study has some 
limitations. Driving is a complex task, influenced by many factors and so it is 
important to emphasise that RNFL thinning and worsening SAP MD account for 
only some of the variability in ability to divide attention during driving simulation. I 
did not assess the relationship between RNFL thickness and motor vehicle 
collisions directly, as collisions are rare and difficult to predict. I instead focused 
on measures of ability to divide attention that have previously been shown to be 
related to collision risk (Owsley, & McGwin 2010; Medeiros et al 2012; Owsley et 
al 1998). Also, divided attention was assessed using a driving simulator rather 
than during on-road driving and it is possible that drivers may show differences in 
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behaviour in real world driving, when the risks to safety are also real. A further 
limitation is that the study included relatively few patients with moderate to 
advanced visual field loss. Had we included more patients with worse field loss, 
the relationship between perimetry and simulated driving performance may have 
been stronger.   
A further potential limitation is that driving is a binocular task, whereas 
SAP assesses vision in each eye separately and I examined the relationship 
between ability to divide attention and SAP MD in the better and worse eyes, 
rather than using a binocular visual field. I have subsequently re-run the analysis 
using integrated binocular visual field sensitivities calculated from monocular SAP 
sensitivities using the binocular summation method described by Nelson-Quigg 
and colleagues (Nelson-Quigg et al 2000).  
There was slightly correlation between reaction times to the simulated 
driving tasks and binocular SAP sensitivity than between reaction times and SAP 
MD in the better or worse eyes alone (Figure 4-26) (ρ = -0.559; P<0.001 for the 
relationship between binocular SAP sensitivity and log10 reaction times for the 
curve negotiation task (compared to ρ = -0.480 and ρ = -0.480 for SAP MD and 
RNFL thickness in the better eye) and ρ = -0.319; P<0.001 for the relationship 
between binocular SAP sensitivity and log10 reaction times for the car following 
task (compared to ρ = -0.315 and ρ =-0.280 for SAP MD and RNFL thickness in 
the better eye). Although binocular SAP sensitivity had the strongest relationship 
with reaction times to the peripheral divided attention stimuli, RNFL thickness still 
provided additional information for predicting ability to divide attention when 
binocular SAP sensitivity was included in the multivariable model.  
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Figure 4-26. Scatter and LOWESS plots showing the relationship between 
integrated binocular visual field sensitivity and reaction times to low contrast 
divided attention stimuli during the curve negotiation and car following simulated 
driving tasks. 
 
 
 
Univariable regression analysis revealed a 0.064 log unit increase in 
reaction time to the curve negotiation divided attention task for each 1dB 
decrease in integrated binocular SAP sensitivity (95% CI 0.049 to 0.078, 
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P<0.001, R2 = 0.343).  There was a 0.058 log unit increase in reaction time for 
each 1 dB decrease in binocular SAP sensitivity (95% CI 0.039 to 0.077, 
P<0.001, R2 = 0.189). The correlation between binocular SAP sensitivity and 
reaction times to the divided attention tasks was similar to the correlation 
between RNFL thickness in the better eye (converted to log units) and reaction 
times (R2 = 0.332, P<0.001 for RNFL thickness in the better eye and reaction 
time to the curve negotiation divided attention task and R2 = 0.184, P<0.001 for 
the car following divided attention task).  
Recently, David Crabb’s group have explored the utility of binocular and 
monocular visual field tests for assessing fitness to drive. They found that SAP 
MD in the better eye is strongly related to legal fitness to drive criteria (Saunders 
et al 2012). Their study, which included 2,604 patients with glaucoma and visual 
field damage in both eyes, found SAP MD in the better eye to achieve an AUC of 
0.962 for discriminating patients meeting and failing the UK visual field criteria 
assessed using the surrogate of integrated binocular visual field. Using SAP MD 
from both eyes offered no additional information. The results of my work suggest 
slightly better correlation between binocular SAP sensitivity and performance on 
a simulated driving task than SAP MD in the better eye, however inclusion of 
information from structural tests may further improve the ability to determine 
ability to safely drive. It is however possible that functional tests that employ 
different test strategies to the 24-2 used in this study, may negate the additive 
predictive ability of structural measures.  
Although I did not examine whether the location of visual field loss was 
related to driving task performance, a recent study has shown loss of the superior 
visual field to have a larger impact on ability to detect hazards when viewing 
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driving scenes than loss of the inferior visual field (Glen et al 2015).  It has also 
been shown that drivers with glaucoma may exhibit different eye movement 
behaviour compared to healthy subjects, which is likely to vary depending on the 
location of field loss (Zhu et al 2014; Crabb et al 2010). It is also important to 
acknowledge that I did not examine whether drivers met the visual criteria for 
legal fitness to drive, which in the UK includes the Esterman binocular visual field.  
However, it has previously been shown that integrated binocular visual fields and 
Esterman visual fields have good agreement for classifying patients as pass or 
fail for UK visual field component of fitness to drive (Crabb et al 2004). In a study 
of 65 patients, Crabb and colleagues found 44 (68%) were classified as pass by 
both integrated binocular and Esterman visual fields, 13 failed both tests, and 8 
failed the integrated visual field but not Esterman.  
Despite the limitations of this phase of my research, this study furthers 
understanding of the relationship between structural and functional changes in 
glaucoma, and helps provide evidence that structural changes are relevant to the 
patient. I found drivers with glaucoma to have slower reaction times to low 
contrast divided attention tasks during simulated driving, which is likely to indicate 
increased risk of collision.  Although worse performance on SAP was also 
associated with worse ability to divide attention, RNFL thinning on OCT provided 
additional information. These findings help explain why drivers with glaucoma are 
at increased risk of collisions and help validate the use of structural 
measurements to quantify glaucomatous changes, however it is important to 
emphasise that structural measurements complement functional testing and do 
not replace it. The study also suggest that combining information from structural 
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and functional tests may improve our ability to determine which patients might 
have problems performing daily activities, such as driving.  
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5 SECTION IV: CONCLUSIONS 
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5.1. Summary 
The results of this body of work can be summarised as follows: 
1. Various models have demonstrated good correlation between structural and 
functional parameters in glaucoma as long as appropriate measurement 
scales are used. However, some discordance between structure and function 
is to be expected, for example, functional changes may be noted in the 
absence of detectable structural change due to RGCs becoming 
dysfunctional prior to changes in their axonal diameter measurable as a 
reduction in RNFL thickness on OCT.  Conversely, due to factors such as 
incomplete spatial summation, high test-retest variability, and differences in 
dynamic range between instruments, in some patients, structural changes 
may be detectable prior to functional changes. The result is that for optimal 
detection of glaucoma and glaucoma progression there is a continued need 
to test both domains. 
 
2. Correlation between results of structural and functional tests suggests that 
detection of change to the ONH or RNFL is clinically relevant for patients, 
i.e., structural changes are related to the clinically relevant outcome of 
deterioration in visual field. Though the structure-function models which 
helped elucidate this relationship are cross-sectional, longitudinal studies 
have also shown a relationship between progressive structural changes and 
worsening visual field. For example, faster rates of RNFL loss detected by 
OCT, or faster rate of rim loss detected by CSLO, are associated with 
increased future risk of worsening visual field.  These studies should not be 
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interpreted as proof that structural changes always precede functional losses 
though as, in some patients, a reduction in DLS on SAP is detected before 
changes to the ONH are apparent. 
 
3. Structural changes in glaucoma include localised loss of the RNFL, a feature 
traditionally considered an early manifestation of disease. The current body 
of work has suggested that rather than be an early manifestation of disease, 
localised RNFL defects visible on photographs may be associated with large 
neural losses. On average, eyes with RNFL defects had an estimated 39% 
fewer RGCs compared to similarly aged healthy eyes, despite an average 
SAP MD of only -3.3 dB. As part of this body of work I attempted to estimate 
RGC losses in eyes with localised RNFL defects but found major flaws in the 
formulae proposed for RGC estimation. Harwerth’s method for RGC 
estimation has been cited in many peer review articles as a useful tool, 
however I would recommend it is not used before further histological 
validation. The formulae were derived from experiments in non-human 
primates by examining the relationship between OCT RNFL thickness, SAP 
sensitivity and histological counts of RGC number. However, there was wide 
disparity in RGC counts for a given RNFL thickness or SAP sensitivity and 
the formulae include several incorrect assumptions, not least use of the 
wrong axonal diameter. During the course of my study, as I became aware of 
these limitations, I decided to abandon use of this method of RGC 
estimation. 
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4. Glaucomatous damage often occurs at different rates in each eye leading to 
asymmetry. If glaucoma is sufficiently asymmetric, asymmetry of the pupillary 
response can be detected as a RAPD. The results of my work revealed 
strong correlation between magnitude of RAPD and inter-eye differences in 
RNFL thickness and SAP MD.  A larger magnitude RAPD is therefore likely 
to indicate greater asymmetry of each of these parameters.  The swinging 
flashlight test, the most common method of identifying a RAPD in clinical 
practice can detect a RAPD of approximately 0.3 log units, which equated to 
an inter-eye difference in RNFL thickness of 6 µm or an inter-eye difference 
in SAP MD of 3.5dB if the average MD is -5dB or 6dB if the average MD in -
15dB. 
 
5. Finally, this body of work has demonstrated an association between 
glaucomatous structural change and impaired performance on simulated 
driving, to the best of my knowledge the first study to reveal such an 
association. I found drivers with glaucoma had impaired ability to divide 
attention during simulated driving, particularly under low contrast conditions. 
Patients with thinner RNFL in the better eye tended to have worse ability to 
divide attention. Worse SAP sensitivity in the better eye and worse binocular 
SAP sensitivity were also strongly correlated with worse driving simulator 
performance, however, structural information was of additional predictive 
value, even when results of SAP were taken into account. The results should 
not be interpreted that structural measurements are superior to SAP, but 
rather that they provide complimentary information that, when used with 
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SAP, may improve our ability to gauge the impact of glaucoma on at least 
one important activity of daily living.   
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5.2. Impact 
The results of this body of work suggest that information from structural 
measurements could be combined with information from functional tests to 
improve predictions of the impact of glaucoma on the ability to perform tasks of 
daily living. Driving was the sole task examined in this work, however, it is 
probable that combining information from structural and functional tests may be a 
useful strategy for predicting the impact of glaucoma on other activities; an 
important area for further study.     
Together with previous experiments that have demonstrated progressive 
structural changes to be predictive of future decline in visual function, the current 
work provides evidence that structural measurements are relevant to patients. 
This may help decisions regarding whether structural measurements could be 
valid surrogates as endpoints for clinical trials. As structural changes often 
precede detectable changes on perimetry and as psychophysical tests are often 
subject to considerable test-rest variability, the use of structural endpoints, or 
endpoints consisting of a combination of information from structural and 
functional tests, may allow the length of trials to be shortened. 
It should however be noted that patients enrolled in the current studies 
performed only a 24-2 visual field. Although SAP remains the gold standard for 
assessing functional loss in glaucoma, this work suggests that conventional 24-2 
perimetry fails to fully capture the impact of glaucomatous neural losses. This 
may be because the 24-2 samples only 24 degrees of the retina and has 
relatively few test points in the central field, or be due to the inherent variability of 
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psychophysical testing reducing the association between metrics. It is possible 
that the additional value of the measurements from OCT may have diminished if 
information from alternative functional tests had been included. For example, 
incorporation of data from 10-2 visual fields may have reduced the additional 
value of OCT. Nevertheless, multiple studies have shown that structural and 
functional changes are rarely detected simultaneously.  
It is conceivable that a driving risk prediction tool might be developed that 
combines information from SAP and OCT to identify patients with impaired ability 
to divide attention. Impaired ability to divide attention whilst driving has potentially 
serious consequences, as it is likely to affect the ability of a subject to perceive a 
dangerous situation in a timely manner and is associated with increased risk of 
collision. Patients identified as high risk could then undergo more detailed 
scrutiny of their driving, for example, with a simulated or on-road assessment. By 
monitoring changes on OCT and SAP it may also be possible to estimate the 
lifetime risk of losing one’s driving licence, similar to current visual field trend-
analyses used to predict lifetime risk of visual loss. Such a tool could help identify 
those who might benefit from escalation in treatment at an earlier stage and avoid 
unnecessary treatments for those at low risk. By incorporating structural 
measurements into predictions of glaucoma progression, it may also be possible 
to improve predictions of the impact of disease on ability to perform other tasks. 
Put simply, improved understanding of the relationship between commonly 
measured clinical metrics and activities of daily living may allow clinicians to 
better appreciate the significance of changes in SAP and OCT to patients.  
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My conclusion is that both structural and functional tests are important and 
that rather debate which test is best, future research should focus on developing 
methods of integrating the results from both domains to better understand the 
impact of glaucoma on patients.  
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5.3. Future Work 
Since returning to clinical practice I have been fortunate to secure funded 
research time from NHS Research Scotland, which has enabled me to continue 
the collaboration with UCSD and begin to develop my own research programme. 
In collaboration with UCSD I have continued to investigate the impact of 
glaucoma on driving and the next stage of this work is to conduct a longitudinal 
study to examine the relationship between change in structural and functional 
parameters and driving performance over time. Further validity would also be 
gained by examining whether objective measures of glaucomatous damage are 
related to real-world on-road driving metrics. In the UK, the current visual field 
standard for driving is assessed using the Esterman visual field test, which was 
not designed for this task, and has a lack of evidence to support its use. It is 
conceivable that a battery of tests, including SAP and OCT may be a better 
discriminator of whether a person has sufficient sight to safely drive, and further 
research comparing Esterman to other clinical tests is needed. 
Dr Medeiros’ team have also begun evaluating the relationship between 
conventional measures of glaucoma and the ability to perform other common 
tasks such as walking and searching for objects. This has involved building 
computer simulations displayed using a virtual reality headset, which allows 
development of a set of standardised scenarios, with eye tracking used to 
measure response times and examine search strategies. We have established 
that a combination of information from structural and functional tests is required; 
therefore, an important area of future study should be the development of better 
methods of integrating measurements. For example, using Bayesian statistical 
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methods to modify predictions of decline in SAP using prior information from 
OCT, with the possibility of also adding information regarding other risk factors to 
the model.  
Arguably the most important structure-function relationship is the 
relationship between structural changes and quality of life. In collaboration with 
Carolina Gracitelli, a PhD student at UCSD, have recently conducted a study 
examining this issue (Gracitelli et al 2015). 260 subjects with glaucoma  were 
followed for an average of 2.5 years. All were asked to complete the 25-item 
National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and changes 
in visual field and structural measurements were compared to changes in self-
reported quality of life. We found patients experiencing faster rates of RNFL loss, 
measured using OCT, had faster rates of decline in quality of life and in 
agreement with the results of my investigation of driving simulation, information 
from structural testing provided additional information explaining patient-reported 
outcomes even after adjusting for the contribution of SAP. This study was limited 
by the potential bias introduced by patient’s knowledge of their progression 
status; in other words, patients’ perceptions regarding quality of life may have 
been influenced by being told they were progressing rather than by deterioration 
in quality of life due to the disease process.  Nevertheless, it adds to the evidence 
that information from structural tests can provide additional value to conventional 
measures of visual function alone when assessing the impact of disease on 
patients. 
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During the course of my research, I became more aware of the limitations 
of the current tests available in clinical practice, in particular the limitations of the 
24-2 SAP testing strategy. A major focus of my current work is the attempt to 
develop an improved psychophysical test. Together with engineers from 
University of Edinburgh we have been designing a new perimetric test that, rather 
than require the patient to press a button, uses eye-tracking to assess responses 
to seen stimuli. The patient is permitted to move their head during testing and 
does not need to keep their chin on a rest. Preliminary results suggest that 
patients prefer eye tracking perimetry to conventional SAP and we have received 
funding from the International Glaucoma Association to develop the test further. It 
is conceivable that as the test more closely reflects the real world environment, 
where patients are free to move their head and eyes to detect visual stimuli, the 
results from this test might be better correlated to ability to perform vision-related 
tasks of daily living than SAP.  
A final further interesting area of study is the importance of macular 
changes in glaucoma. Until recently imaging in glaucoma has primarily focused 
on assessment of the ONH and RNFL, however, as the macula contains 
approximately 50% of RGCs, imaging the macula may provide additional 
information in the assessment of glaucomatous damage. Glaucomatous changes 
in the macula are also likely to have particularly serious consequences for quality 
of life given the importance of central vision. As the macula is largely devoid of 
large vessels and has a readily identifiable centre, assessment of this region may 
also overcome some limitations of circumpapillary measurements, such as 
interference from retinal and optic nerve head vasculature, parapapillary atrophy, 
and variable placement of the measurement circle around the disc. Future 
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studies should assess whether combining information from OCT of the macula, 
RNFL or ONH, and SAP further improves our ability to measure and understand 
the consequences of glaucoma for our patients.  
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